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This thesis describes the isolation and structure elucidation of secondary metabolites 
from a number of endophytic Xylaria fungi. Six Xylaria endophytes were surface 
cultured on an aqueous malt extract-glucose medium. The fungus A311R, from a 
palm tree in Thailand, produced nonane-1,2,3-tricarboxylic acid, which was isolated 
for the first time as a natural product. Also isolated from the same fungus was 
spiculisporic acid; the first instance of isolation from a Xylaria fungus. The fungus 
6RD12 produced cycloepoxydon, which was isolated for the first time from a 
Xylaria fungus, and 4,5,6-trihydroxy-3-propyl-3,4,6,7-tetrahydro-l//-isochromen- 
8(5//)-one, which is a novel compound. The fungi A217R and A517R produced 
cytochalasin D, (S)-mellein and (3S,4S)-4-hydroxymellein as main secondary 
metabolites suggesting that the two fungi are the same species. The fungus X04 
(Xylaria cf. juruensis) produced 2-Hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien- 
1,4-dione as a novel compound, coriloxin as the main secondary metabolite in 
addition to (R)-mellein and a mixture of two stereoisomers of the 4-Hydroxymellein. 
The fungus 6RD8 produced (S)-Omethylmellein as the main secondary metabolite.
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Chapter 1
Chapter 1 Introduction
1.1 The Family Xylariaceae
Xylariaceae is a family of fungi belonging to the Ascomycota which traditionally has 
been divided into three main subclasses, plectomycetes, discomycetes and 
pyrenomycetes. The Xylariaceae belongs to the pyrenomycetes subclass. This family 
comprises of at least 40 genera 1-3 but nearly70 genera have now been listed 4. The 
main habitat of the majority of the genera is wood 3 and most xylariaceous fungi are 
saprophytic and are found in decomposing wood, litter, fruits, seeds and leaves5'7. 
Additionally, many studies have shown that members of the Xylariaceae occur as 
endophytes 8' 10; living inside healthy plant tissues without causing any external 
disease symptoms n'12. Endophytic fungi have been shown to be promising 
producers of valuable products for the pharmaceutical and agricultural industries 13.
In 1979 using morphological data, Rogers 5 proposed a central core of genera for the 
family Xylariaceae comprising: Hypoxylon, Rosellinia, Poronia, Podosordaria, 
Hypocopra, Daldinia, Nummalaria, Kretzschmaria, Camillea and Penzigia.
In 1995 Whalley 14 proposed a scheme illustrating the relationships between these 
genera ( Figure 1). The taxonomic classification of fungi species has been attempted 
in different ways. This includes use of:
- mycological data 15"16'
- chemical data 17’18,
1
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Figure 1 Scheme illustrating the relationships between Xylariaceae genera. 
1.2 The Genus Xylaria
Xylaria is the oldest known genus of the family Xylariaceae. They are widespread 
around the world 19 and more than 500 species are believed to belong to this genus 
(Rogers, pers comm.). The fact that Xylaria species vary in shape, colour and size 
and the fact that they can appear to be different during different stages of maturation, 
has resulted in their classification being confused and as a result one species can 
have more than one name. Stromatal morphology was used in early research as the 
main basis for classification of Xylaria species 20'21. Several attempts have been 
made to classify Xylaria and the most reliable one was derived in 1985 by Rogers 22' 
23 (Table 1), who used in place of the morphology of stromata (teleomorph) in the 
life cycle the morphology of the conidia (anamorph) produced by the fungi as main 
characters for classification.
Although this system is more satisfactory, it is incomplete, and many gaps need to be 
filled because not all the species have been cultured and few Xylaria species have 
anamorphic data. Until now no stable classification system is available for Xylaria
2
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genera. The use of chemotaxonomy could help to highlight the relations between the 
different species 24.
Table 1 Classification of Xylaria genera according to Rogers 22-23
Section Characteristic features
1 Conidia produced from palisade of conidiogenous cells over active young 
telemorphic stromata or at least not limited to specialised appendages, 
Conidiogenesis holoblastic. Conidia produced in more or less sympodial 
sequence, seeding individually and passively. This section contains 5 
groups: Xylaria polymorpha, X. hypoxylon, X. multiplex, X. pyramidata 
and X. pedunculata.
2 Conidia produced on special and localised peg or hairy-shaped appendages 
on young teleomorphic stromata, Conidia apparently seeding individually 
and passively. This section is represented by the X. comosa group.
3 Conidia produced on special anamorphic stromata or conidiomata which 
usually are produced earlier in the year than telemorphic stromata. 
Telemorphic stromata never bear conidia, Conidiogenesis holoblastic. 
Conidia produced in more or less sympodial sequence, seeding 
individually and passively.e.g X. cubensis.
4 Conidia produced on young telemorphic stromata. Conidiogenesis 
apparently holoblastic. Conidia produced in tendem seeding forcibly. This 
section is represented by X. furcata.
1.3 Secondary metabolite profile
A fungal secondary metabolite is a chemical compound produced by a limited 
number of species in a genus, an order, or even phylum, and has high differentiation 
power 18. Secondary metabolites can only be used as taxonomic markers with good
3
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producer fungi, which can be grown under controlled laboratory conditions. Over 40 
years of study have shown the fungi secondary metabolites are reliable and valuable 
taxonomy markers 14,25. Frisvad 26 in 1990 demonstrated that secondary metabolite 
profiles of Talaromyces were specific for each species and provided means of simple 
differentiation of taxa and highlighted their potential in ascomycete taxonomy. It is 
not unusual that different fungal species have one or more secondary metabolites in 
common. Cytochalasin D is one such metabolite. It is produced by several fungal 
species 21. The major secondary metabolites produced by different fungal species in 
aqueous culture can be divided into a number of chemical groups including, 
dihydroisocoumarins and related compounds, sesquiterpene alcohols, cytochalasins 
and succinic acid derivatives 28. The whole range of secondary metabolites, that have 
been isolated from various Xylaria species are illustrated in Table 2.
4
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Table 2 Secondary metabolites from Xylaria species
N Compound structure Xylaria species Other species
1 COOH
y— /  ^ —COOH
(E)-2-Hexylidene-3- 
methylsuccinic acid
X. polymorpha
29
X. mali29 
X. hypoxylon 29 
X. longipes 30 
X. multiplex30 
X. myosurus 31
H. deustum 
P. pileiformis
29
2
HOOC^ \= =
) —COOH 
HOOC—/
Telfairic acid
X. telfairi32
3
A /  ^•" 'V -C O O H
° - 4  /
0 \
2,3-Didehydrotelfairic
Anhydride
X. telfairi32
4 O OH o
CHO 0H
Xylaral
X. polymorpha
33
5 V —  OH OH
HO-a / ^ O H  7^ - T  OH 
'j ' / y-cocH
X. cubensis 34
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C u b e n s i c  a c i d  (C 3 0 H 5 3 O 7 )
6
OH OH OH OH 
CHj CH, CHj CHg CH3 CH)
C a m e r o n i c  a c i d  (C 2 6 H 4 4 O 6 )
Xylaria f r o m  
C a m e r o o n  35
7 OH OH OH OH OH 
CHj CHs CHj CHj CHj CHj CH^  CH,
B e r t e r i c  a c i d  (C 3 0 H 5 2 O 7 )
X. b e r t e r i i 33
8
OH OH OH OH 
CH, 1* 0*  CH3 CHj CH3 CHj
M a l a y s i c  a c i d  (C 2 9 H 5 0 O 7 )
Xylaria s p e c i e s  
M a l a y s i a 35
1 0
O X C Q -
S  0AC / b H '°
C y t o c h a l a s i n  D
X .  c u b e n s i s  34 
X .  s p e c i e s 36
H .  t e r r i c o l a  3/
1 1 * 1  OH
crxXOr5  O A c  < ^ 0
C y t o c h a l a s i n  C
X .  s p e c i e s 3b H . t e r r i c o l a 3 '
1 2 OH
......
HNv W V 4
S  OAC
19,20- e p o x y c y t o c h a l a s i n  C
X .  o b o v a t a 38 
X .  h y p o x y l o n 39
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13
J k °
airn-
5 0Ac * 5 ? °
Cytochalasin Q
X. obovata38 
X. hypoxylon39
14 : 0
^ ■ ' ■ ' V S r o ^ S ....
HNV W V (
5  oAc ^ v T " °
Xylobovatin
X. obovata38
15 : 0
n ' V T c \ ....
^  H^ w \ i
8  OAc ^ 0
19,20-epoxycytochalasin Q
X. hypoxylon 39
16
0
8  OAc / Q - 0
Cytochalasin R
X. hypoxylon 39
17 I-'0
O  HNV ° ^ ° W = °A II * oh °  o
Cytochalasin E
Rose 11 in ia
• 4ftnecatrix
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18 O J
• - ..L X ^ oh
OXCQ-II O A r0  UAC OH 
Cytochalasin N
X. species 3b Hypoxylon 
terricola 41
19 v OH ... OH
h0 t  jC h
A ' Y Y ^ .......
HN y W i
0  0Ac OH 0 
Cytochalasin O
Xylaria species
36
Hypoxylon
terricola41
20 OH
CKi0
Xylaramide
X. longipes ^
21
H0~ ' i l ' ^ 0H
2,5-di(hydroxymethyl)furan
X. longipes44 Phellinus 
linteus 42
22
h° - 0  ^^  OH
Tyrosol
X. longipes 44
23 o c h 3
OH p^COOH
'N p 5Y ^ 0H
y ^ O H
COCH3
Globoscinic acid
X. globosa44 
X. obovata 43
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24 O H  W 0 C H 3
^ JL V 
Y Y ^ °
c o c h 3
Globoscin
X. globosa43 
X. obovata 43
25 0
V o
Longianone
X. longiana31
26
P 7
0
S-8-O-methylmellein
X. species 36
27 0
Mevalonolactone
X. species 3b
28 0
/ T O o M e  
HO H
Coriloxin
X. species3(1 
X. obovata 43 
X. badia44
Coriolus 
vemicipes 45
29
W
OH 0  
Mellein
(S) isomer:
X. grammica36 
(R) isomer:
X. longiana 31 
X. badia 44
Hypoxylon 
howieanum 46 
Aspergillus 
oniki 47 
Aspergillus
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X. species3b melleus48
30 COOH 
OH 0
5-carboxymellein
X. species3b 
X. myosurus 31
Hypoxylon
illitum,
Hypoxylon
mammatum
46
31
O o r
Xylaric acid
X. species
32
OH 0
4-hydroxymellein
X. grammica36 
X. longiana19
Aspergillus 
oniki 47 
Aspergillus 
ochraceus50 
Aspergillus 
melleus48,32
33 OH
Grammicin
X. grammica36
10
Chapter 1
34
' ~ T Y a ?
C a °
hoocohc^  
Feejeensci acid
X. feejeensis
35
OH o
8-hydroxy-7-hydroxymethyl-6-
methoxy-3-methylisocoumarin
X. species Jt)
36 h3co^ y ^ /
O H C ^ Y i r
OH O
7-formyl-8-hydroxy-6-methoxy-
3-methylisocoumarin
X. species Jb
37
OH O
3,7-dimethyl-8-hydrxy-6-
methoxyisocoumarin
X. speciesJ(>
38 OH
OH •
4,8-dihydroxy-1 -methy 1 -3-oxo- 
isochroman-7-carboxylic acid
X. species Jt>
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39 HOOC^ __^CH2)3CH3
h3c cooh
2-n-butyl-3- methylsuccinic acid
X. species
40 0H?  o h .cho 
OH
Deacetylbotrydial
X. species Jt>
41 %OH
Deacetyldihydrobotrydial
X. species
42 OH 0
A A 0 ?00Me
o ^ ' f '  och3
Cl
Maldoxin
X. species iZ
43 HO COOH 
OH
Myosuric acid
X. myosurus J1
44 CH,OH 
OH 0
5-hydroxymethylmellein
X. myosurus il Hy poxy Ion 
¡11 ¡turn,46 
Valsa
ceratosperma51
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1.4 Endophytes
Endophyte (Gr. endon, within; phyton, plant) the term was first coined by de Bary in 
1866 and has become deeply embedded in the literature ever since 52'53. Stone et al 
defined endophytic organisms as ‘microbes that colonize living, internal tissues of 
plants without causing any immediate, overt negative effects 54. First reports 
describing endophytes date back to the beginning of the twentieth century 5S.
Fungi and bacteria are the most common microbes that can exist as endophytes. But 
the most frequently isolated endophytes are the fungi 56. Examination of plant 
material can lead to the discovery of several endophytic fungi and bacteria. Many 
fungi would be specific to that particular host 57. So it is noteworthy that, of the 
nearly 300,000 plant species that exist on the earth, each individual plant can be host 
to one or more endophytes.
The number of endophytic species potentially associated to a plant species can reach 
several hundred58.
Furthermore, the colonization of endophytes in marine algae 59 mosses and ferns 60'61 
has also been reported. Only a few of these plants have been completely studied 
relative to their endophytic biology 56. It is believed that up to 99% of 
microorganisms have yet to be discovered .
Consequently, environmental conditions such as temperature, soil and humidity, are 
considered to affect the nature and the number of endophytes 63.
Many scientists believe that plants growing in tropical rainforests, where competition 
for light and nutrients is fierce, are mostly host for bigger numbers of bioactive 
endophytes. Researchers recently noted that endophytes from tropical regions 
produced significantly more bioactive secondary metabolites than those from 
temperate parts of the world 64'66.
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The question of how microbial endophytes get into their host plants is still not clear. 
Obviously most microbial fungal endophytes can gain access through the roots, but 
bacterial endophytes are not thought to invade plant tissue directly; instead, they tend 
to enter the plant through natural openings or wounds 67. Endophytes may also infect 
plants by means of horizontal transmission, when their inocula are transported to 
another plant, or vertically when they infect the seed progeny of an infected plant68.
1.5 Endophytes and their host relationship
Endophytes that colonize the interior of plant tissues usually get nutrition and 
protection from the host plant. In return, they grant profoundly enhanced health to 
the host plants by producing certain functional metabolites 69.
Scientific observations show that endophyte-infected plants often grow faster than 
non-infected ones 70'71. It thought that the endophytes improve the hosts intake of 
nutritional elements such as nitrogen 72 and phosphorus 73'75
Additionally, some endophytes are able to support the host plant with defence 
against some nematodes 76-77 and insect herbivores 78-80 as well as bacterial and 
fungal pathogens.81-82.
1.6 Natural products and drug discovery
The fact that the human population is always exposed to new diseases such as AIDS 
and severe acute respiratory syndrome requires the discovery and development of 
new drugs to fight them.
Also more drugs are needed to efficiently treat parasitic protozoan and nematodal 
infections, such as malaria, leishmaniasis, trypanomiasis, and filariasis 56. Malaria 
alone causes more deaths each year than any other single infectious disease with the 
exception of the AIDS virus and Mycobacterium tuberculosis 83.
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Today natural product research still has massive impact on modem medicine 
development in that 49% of the new chemical products registered by the U.S. Food 
and Drug Administration are natural products or derivatives84.
More than 20 natural product derived drugs were launched onto the global market 
between 2001 and 2005 and have undergone various stages of clinical development 
in all major therapeutic fields 85'86.
Over, 3,000 years ago, the Mayans used fungi grown on roasted green com to treat 
intestinal ailments 87, whilst the Benedictine monks (800 AD) used Papaver 
somniferum as an anaesthetic and pain reliever88.
The existence of endophytes has been known for over 100 years55,69. It was however 
only during the later decades that endophytes have been investigated for their 
potential as sources of effective new drugs. Nowadays, endophytes are known to 
provide many modem medicines such as penicillin from the fungus Penicillium 
notatum, and bacitracin from the bacterium Bacillus subtilis. In addition, scientific 
researchers show that some plants which produce bioactive natural products have 
associated endophytes that produce the same natural products. This can lead to a 
more economical production line to an expensive drugs and products and effectively 
reducing its market price56. For instance paclitaxel, a highly functionalized 
diterpenoid and important anticancer agent that is found in the world's yew tree 
(Taxus spp.) 89, has been found to be produced by a novel paclitaxel-producing 
fungus, Taxomyces andreanae, from the yew Taxus brevifolia 90. This raised a 
concept of genetic recombination of the endophyte with the host that can occurs 
during evolutionary time 69.
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1.7 Natural products from endophytic fungi
Natural products from endophytic microbes have been observed to inhibit or kill a 
wide variety of harmful disease-causing agents including, but not limited to, 
phytopathogens, as well as bacteria, fungi, viruses, and protozoans that affect humans 
and animals 56
The secondary metabolites isolated from fungal endophytes have different 
biosynthetic pathways: isoprenoid, polyketide and amino acid derivatives. They 
belong to different structural categories: alkaloids, peptides, steroids, terpenoids, 
quinones, flavonoids, aliphatic compounds, and phenols, etc.
1.7.1 Alkaloids
Alkaloids are quite common secondary metabolites from endophytes, and some of 
them show antimicrobial activity.
Amines and amides are quite common isolates from Acremonium endophytes which 
was reclassified as genus Neotyphodium 91.
Peramine (1), a pyrrolopyrazine alkaloid, was extracted from Neotyphodium 
coenophialum, N. lolli, Epichloe festucae and from E. typhina 92.
16
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This secondary metabolite showed toxicity to insects with no harmful effect on 
mammals 93'94.
Another group of compounds that possess antitumor and antibiotic activities are the 
cytochalasins. Cytochalasins are alkaloids which are commonly produced by 
endophytic fungi such as Xylaria, Phoma, Hypoxylon, and Chalara genera 9S. 
Furthermore, three new cytotoxic cytochalasins (2-3), together with the known 
metabolite cytochalasin E (4) were characterized from the culture of Rhinocladiella 
sp., an endophyte present in the perennial twining vine of Tripterygium wilfordii95.
Two newly reported antibiotics, pyrrocidines A (6) and B (7) were isolated from the 
endophyte Acremonium zeae in maize and displayed significant antifungal activity 
against Aspergillus flavus and Fusarium verticillioides 96.
6 7
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Recently, a tetramic acid analogy cryptocin (8), an effective antimycotic against 
Pyricularia oryzae and other phytopathogens, was characterized from the culture of 
an endophytic fungus Cryptosporiopsis cf. Quercina 91, which was found in the inner 
bark of the stems of Tripterygium wilfordii98.
8
Indole alkaloids such as chanoclavine (9), agroclavine (10) and elymoclavine (11) 
were isolated from a culture of Neotyphodium endophytes 
OH R
10 agroclavine R=H
” 11 elymoclavine R= OH
Some endophytes can produce plant hormones with an indole framework 69. The 
growth-enhancing phytohormone indole-3-acetic acid (IAA, 12) was isolated from 
cultures of an endophytic fungal endophyte Acremonium coenophialum 10°, 
Aureobasidium pullulans and
12 R= COOH
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Epicoccum purpurascens 101 and Colletotrichum sp., an endophytic fungus in 
102Artemisia annua
The alternative production of endophytes for phytohormones is assumed to be 
related to the plant growth-promoting effect allowed by the endophyte infection69.
1.7.2 Steroids
Two new steroids, 3ß-5a-dihydroxy-6ß-acetoxyergosta-7,22-diene (13) and 3ß,5a- 
dihydroxy-6ß-phenyl- ./Va/acetoxyergosta-7,22-diene (14) were characterized from 
the culture medium of an endophytic fungus Colletotrichum sp. of A. annua. 
Metabolites 60 and 61 were shown to be antifungal against some crop pathogens 
Gaeumannomyces graminis var. tritici, Rhizoctonia cerealis, Helminthosporium 
sativum and Phytophthora capisici .
13
Most steroid compounds isolated from endophytes only showed moderate 
antimicrobial activities, so it appear to be quite difficult to find effective steroid
103drugs or pesticides from endophyte
1.7.3 Terpenoids
Terpenoids have often been isolated from endophyte cultures which colonize a 
variety of host plants. Heptelidic acid (15) and hydroheptelidic acid (16) 
characterized from Phyllosticta sp., an endophytic fungus of Abies balsamea, were
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found to be toxic to spruce bud worm (Choristoneura fumiferana) larvae 104. Two 
new benzofuran carrying normonoterpene derivatives (17) and (18), have been 
isolated from a culture of an unidentified endophytic fungus obtained from 
wintergreen Gaultheria procumbens 105.
HO. oH
17 R= 0
18 R= OH, H
A novel diterpenoid, Guanacastepene (19), produced by an unidentified fungus from 
the branch of Daphnopsis Americana growing in Guanacaste, Costa Rica, was found 
to exhibit antibacterial activity against methicillin-resistant Staphylococcus aureus 
and vancomycin-resistant Enterococcus faecium 106.
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Subglutmol (20), an isolate of Fusarium subglutinans, an endophytic fungus from 
the perennial twining vine Tripterygium wilfordii was found to be 
immunosuppressive but not cytotoxic 107.
Paclitaxel (Taxol (21)), a highly functionalized diterpenoid possesses outstanding 
antioomycete activity, is found in each of the world's yew (Taxus) species 89. 
Paclitaxel and some of its derivatives are the first major group of anticancer agents 
that is produced by endophytes 56.
Taxol was firstly isolated in extremely small quantities from the inner bark of the 
Pacific yew, Taxus brevifolia, a slow growing Taxus species, is an effective 
anticancer diterpene I08'1U. Taxomyces andreanae, a new endophytic fungus isolated 
from a Pacific yew T. brevifolia in Montana, USA, was the first reported endophyte 
to produce taxol in 1993.
Electrospray mass spectrum technique was used to prove the existence of this 
compound in the culture medium of the endophytic fungus, T. andreanae. In 
electrospray mass spectroscopy, paclitaxel usually gives two peaks, one at a mass of 
854, which is (M + H+), and the other at 876, which is (M + Na*)90. Since then, a 
variety of endophytic fungi belonging to different categories isolated from T. 
Brevifolia 112, T. Wallachiana 1,3, T. yunnanensis, T. baccata, T. Mairei 114, 
Taxodium distichum ll5'" 6, Torreya grandifolia 117, Colletotrichum gloeosporioides
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110 and Wollemia nobilis 118'" 9 have been reported to be able to produce Taxol and/or 
taxane derivatives in some endophyte cultures.
Paclitaxel was also isolated from Pestalotiopsis microspora U3, 120, which was the 
first endophytes residing in plants other than Taxus spp , Pestalotiopsis guepini12U 
122, Seimatoantlerium tepuiense 123.
1.7.4 Isocoumarin derivatives
(7?)-Mellein (22), an isocoumarin isolated from Pezicula spp. 124, is a powerful 
fungicidal, herbicidal and algicidal. Gamahorin (23) is an isocoumarin characterized 
from stromata of E. typhina on P. pratense .
1.7.5 Quinones
Altersolanol A (24), a highly hydroxylated quinone, found in phytopathogenic 
Alternaría cultures, was reisolated from an endophytic Phoma sp. and found to be an 
antibacterial agent126.
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1.7.6 Peptides
Leucinostatin A (25), an oligopeptide with phytotoxic, anticancer and antifungal 
properties characterized originally from Pénicillium lilacinum 127, was reisolated 
from culture of Acremonium sp., an endophytic fungus from Taxus baccata 128.
25
The cyclopeptides echinocandins A , B, D and H, were isolated from endophytic 
Cryptosporiopsis sp. and Pezicula sp. in Pinus sylvestris and Fagus sylvatica and 
shown to be antimicrobial 129. These metabolites were originally produced by 
Aspergillus rugulosus and A. nidulans var. Echinulatus 13°.
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e c h in o c a n d in s  A  R l=  R 2=  R 3=  O H  
e c h in o c a n d in s  B  R 1=H , R 2=  R 3=  O H  
e c h in o c a n d in s  D  R l=  R 2=  R 3=  H  
e c h in o c a n d in s  H  R l=  R 2=  O H , R 3=  O M e
Cyclo(Pro-Thr) (26) and cyclo(Pro-Tyr) (27) were two new antibacterial compounds 
produced by the fermentation broth of endophytic fungus a Pénicillium sp. isolated 
from mangrove plant Acrostichum aureurm 131.
A unique peptide antimycotic, termed cryptocandin (28), was isolated and 
characterized from C. quercina, a fungus isolated as an endophyte from Tripterigeum 
wilfordii, a medicinal plant native to Eurasia .
OH
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1.7.7 Phenols
Phenol and phenolic acids have often been isolated from endophyte cultures 
originating from a variety of host plants 103.
Pestalachlorides A-C (29-31), three new chlorinated benzophenone derivatives, have 
been isolated from cultures of an isolate of the plant endophytic fungus 
Pestalotiopsis adusta. Pestalachlorides A and B displayed significant antifungal 
activities against three plant pathogens 132.
Another fascinating use of secondary metabolites from endophytic fungi is the 
inhibition of viruses. Two novel human cytomegalovirus protease inhibitors, cytonic 
acids A (32) and B (33), have been isolated from the solid-state fermentation of the 
endophytic fungus Cytonaema sp. Their structures as p-tridepside isomers were 
elucidated by mass spectrometry and NMR methods 133.
32 Cytonic acid A R1 = Et, R2 = H
33 cytonic acids B R1 = H, R2 = Et
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Endophytic fungi can produce compounds with antimicrobial as well as antioxidant 
activity. Pestacin (34) and isopestacin (35), have been isolated from culture medium 
of P. microspora, an endophyte isolated from a plant called Terminalia morobensis 
growing in the Sepik River drainage of Papua New Guinea 134. Both pestacin (34) 
and isopestacin (35) display antimicrobial as well as antioxidant activity 134.
1.7.8 Others
Chaetomellic acids A (36) and B (37) isolated from the culture of an endophytic 
Chaetomella acutisea were found to be specific inhibitors of famesylprotein 
transferase (FPTase) 135.
Sordaricin (38) cultured by the endophytic fungus Jfylaria sp. isolated from the 
leaves of Garcinia dulcis, exhibited moderate activity against a wide range of fungal 
pathogens 136.
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Ambuic acid (39), a highly functionalized cyclohexenone isolated from P. 
microspora, possesses antifungal activity137. This compound has also been used as a 
model to develop new solid-state NMR experiments for the structural determination
138 139of organic substances ' .
39
There is mounting evidence that many bioactive compounds isolated from plants, as 
well as marine and terrestrial invertebrates, are actually metabolites produced by
• . 140symbiotic microorganisms
1.8 The aims of the project
This project is designed to achieve the following objectives:
- Create secondary metabolite profiles of the studied endophytic Xylaria fungi.
- Search for novel and bioactive secondary metabolites produced by 
endophytic Xylaria fungi
- Apply NMR and other spectroscopic techniques to elucidate the structure of 
isolated secondary metabolites.
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C h a p te r  2: S econdary  m etabo lites from  X. A 311R
2.0 Fungus A311R overview
Endophytic fungus A311R was collected from palm tree leaves Arenga pinnata 
(Sugar Palm) from Kao Loung National Park in Thailand.
Arenga pinnata Sample leaf of Arenga pinnata
Figure 2 Arenga pinnata palm tree
The fungus was received from Prof A.J.S Whalley, Liverpool John Moores 
University, as cultures in Petri dishes as shown in Figure 3. The examination of the 
fungus for its secondary metabolites is discussed in this chapter.
Figure 3 Endophytic fungus A311R in Petri dishes.
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The culture of endophyte A311R was sub-cultured in four conical flasks containing 
3% aqueous malt extract for 3 weeks. Fruiting bodies developed after 10 days. The 
light brown fruiting bodies grew 1.0-1.5 cm high with a base diameter of 0.5 mm on 
the black and white upper surface of the mycelium. The mycelium also developed 
white ball-shaped bodies as well (Figure 4).
The cultured endophyte was then transferred into twelve Thompson bottles and 
allowed to grow on 3% aqueous malt extract for 8 weeks. Master cultures of these 
endophytes were made for future reference. The initially white mycelium (4 weeks) 
later turned brittle and black on the underside and supported un-branched, light 
brown-tipped xylaria-type fruiting bodies.
Figure 4 A311R endophytes after ten days
2.1 Isolation and struc tu re  elucidation of nonane-1,2,3-tricarboxylic 
acid (2. 1)
The mature cultures (12 L) were harvested and the mixture filtered through a muslin 
cloth to recover the mycelium. The aqueous filtrate was extracted in batches with 
ethyl acetate in a separating funnel (5 L) and the combined ethyl acetate extracts 
were dried over anhydrous sodium sulphate. Removal of the solvent by rotary 
evaporation gave brown gummy material (4.32 g). The latter was dissolved in warm
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chloroform and set aside for 24 h. A light brownish solid (0.90 g) precipitated from 
the solution. The solid was recovered by filtration and crystallised from nitromethane 
to give nonane-1,2,3-tricarboxylic acid (2.1) as yellowish white crystals (375 mg), 
mp (117-120 °C), ESI [M-H]' m/z 259.1177, [a] 2D° -  186° (c 1.0, MeOH) IR<ATR)Vmax 
cm'1 : 3091,1713, 1659 and 1175. HRESIMS analysis of 2.1 gave a molecular ion at 
m/z 259.1177 in the HR-ESIMS spectrum is compatible with the formula C12H20O6. 
The prominence of the M-18 peak (m/z 241.1) in the ESIMS spectrum of 2.1 is 
indicative of the presence of a hydroxyl group *, which is supported by the IR 
absorption at 3091 cm'1 (Figure 5). The molecular formula suggested three degrees 
of unsaturation, which are possibly due to carbonyl groups, which show absorptions 
at 1713, and 1659 cm'1.
’H NMR spectrum (C5D5N) (Figure 11) showed a methyl triplet at 8H 0.70 (3H, t, J  
6.5 Hz), methylene protons at 8H 1.10 (4H, m), 1.23 (2H, m), 1.47 (1H, m), 1.62 
(1H, m), 1.86 (1H, m), 2.14 (1H, m), 3.46 (1H, m) , 3.23 (1H, dd.73.6, 14.0) and 
two methine protons at 8h 3.50 (1H, m) and 4.12 (1H, m).
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The 13C (Figure 12) and DEPT 135 NMR spectra (Figure 13) run in deuterated 
pyridine revealed 12 carbons: one methyl at 8c 14.04, six methylene signals at 8c 
22.69, 28.32, 29.12, 29.49, 31.77 and 33.94, two methine carbon signals at 8c 44.34 
and 47.42 and three quaternary carbons at 8c 175.50, 176.53 and 177.00. The last 3 
quaternary carbons could be carboxylic acid or ester carbonyls. The IR absorptions 
at 3091 and 1713 cm' 1 supported carboxylic acid carbonyl groups.
The HMQC NMR (Figure 14) and DEPT-135 spectra (C5D5N) allowed the 
assignment of all the protons and their coupling carbon signals (Table 3)
Analysis of the correlations in the 'H-'H COSY (Figure 15) and HMBC NMR 
spectra (Figure 16) allowed the establishment of partial substructure 2.1a. In the ’H- 
’H COSY spectra, H-7b at 8h 1.23 was coupled to H-8a at 8h 1.10 and in addition H- 
9b at 8h 1.10 was coupled to H-10 at 8h 0. 70. The HMBC was useful in the 
assignment of C-7, C-8 and C-9 because of the two and three bond correlations 
between the protons of the methyl group at 8h 0.70 and the methylene carbon C-8 at 
8C 31.77 (Figure 6).
Green arrows: ‘H-'H COSY 
Red arrows: HMBC
Figure 6 Substructure 2.1a
In the ’H-'H COSY spectrum, H-7a at 8h 1.10 is coupled to H-6a at 8h 1.47 and H- 
6b at 8h 1.62, which is further coupled to H-5a at 8h 2.14 and H-5b at 8h 1.86
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respectively. Furthermore H-5a is coupled to the H-4 methine multiplet at 8h 3.50 
which also has coupling with the H-3 methine multiplet at 8h 4.12. The H-2a 
resonating at Sh 3.46 is coupled to H-3 methine, thus completing the network of 
coupling throughout the molecule (Figure 7).
Figure 7 ^ - ’H correlation network throughout compound 2.1
The HMBC spectrum of 2.1 also showed cross peaks between 5H3.46 (H-2a) and the 
signals at 8h 175.5 (C-l 1) and 176.5 (C-l) confirming their positional assignments.
The H2BC spectrum (Figure 17) was also used to track the two bond C-H 
correlations throughout the structure. H2BC together with HMQC experiments 
provides a map of one and two bond correlations 2. The connectivity was easily 
followed throughout the structure. C-2 correlates to H-3, C-3 correlates to H-4, C-4 
correlates to H-5 and C-5 correlates to H-6, etc (Figure 8).
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Figure 8 H2BC connectivity of compound 2.1
Table 3 Full assignment of the protons and their coupling to carbon signals 
_______ in compound 2.1
No 8c 5h H2BC H-H COSY HMBC
1 176.53- C 3.23, 3.46
2 33.94 - CH2 2a: 3.46 (m)
2b: 3.23 (dd J  3.6, 
14.0)
4.12 3.23,4.12
3 44.34 -C H 4.12 (m) 3.46, 3.50 3.5, 3.46
4 47.42 -  CH 3.50 (m) 2.14 4.12, 2.14,
5 29.12-CH2 5a: 1.86 (m) 
5b: 2.14 (m)
3.50, 1.10, 
1.47
1.47, 1.62, 
1.86
6 28.32 - CH2 6a: 1.47 (m) 
6b: 1.62 (m)
1.23 1.47
7 31.77 - CH2 7a: 1.10 (m) 
7b: 1.23 (m)
1.23, 1.10 0.70, 1.10, 
1.23
8 29.49 - CH2 8a: 1.10 (m) 
8b: 1.23 (m)
9 22.69 - CH2 9a: 1.10 (m) 
9b: 1.10 (m)
1.10, 0.70 0.70 0.70, 1.10
10 14.04-CH3 0.70 (3H,t, J  6.5) 1.10 1.10
11 175.5- C
12 177.00- C
This spectral data identifies compound 2.1 as nonane-1,2,3-tricarboxylic acid 
(Figure 9).
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o  H° \ ^ C n  
1 2
O ^ - O H  
Figure 9 Nonane-1,2,3-tricarboxyIic acid (2.1)
This is the first isolation of this compound from a natural product source. It is also 
the first report of the NMR data for nonane-1,2,3-tricarboxylic acid. This compound 
was synthesized for the first time in 1950 (mp 150 °C) for bioactivity studies, but 
there was no NMR data reported 3. It was found to be inactive against M. 
Tuberculosis bacteria3.
Jayasuriya et al in 1996 reported the isolation of a related compound, oreganic acid 
(C22H38O10S) from an endophytic fungus isolated from living leaves of Berberis 
oregano, which has the structure shown in Figure 10 4. It was found to exhibit
. • 4anticancer properties .
o H<N ^ °
'(C i6H32)------- OSO3H
O '  O H
Figure 10 Structure of Oreganic acid
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2.1.1 Trimethyl nonane-l,2,3-tricarboxylate (2.1A)
To confirm the structure of 2.1, the methyl ester derivative was prepared. Reaction of
2.1 with diazomethane gave a trimethyl ester (2.1A) confirming the presence of 3 
carboxylic acid groups in the parent molecule. The ester (2.1A) gave a molecular ion 
at ES [M+H]+ m/z 303 which is consistent with the molecular formula C15H26O6. The 
mass spectrum also showed a strong ion at m/z 271 corresponding to the loss of a 
methoxy group from the parent ion. The IR spectrum showed the absence of 
carboxylic groups and the appearance of an ester stretching absorption at 1732 cm'1. 
The ’H NMR spectrum (C5D5N, Figure 18) showed the protons at 5h 0.72 (3H, d, J  
7.0 Hz), 1.08 (6H, m), 1.23 (2H, m), 1.49 (1H, m), 1.73 (1H, m), 2.77 (1H, dd, J  
4.3, 12.5), 2.92 (2H, m), 3.43 (1H, m), 3.52 (3H, s), 3.59 (3H), 3.61 (3H, s).
The 13C NMR spectrum of 2.1 A (Figure 19) showed three carbonyl signals at 8C 
172.28, 173.50 and 174.25, which represent shifts of approx. 3 ppm to higher field 
compared to their positions in the parent molecule.
14
MeO. . O
HI
15
2.1A
Compared with the parent, the ]H NMR spectrum shows 3 extra signals 
corresponding to the methoxy protons at 8h 3.52, 3.59 and 3.61, which in turn
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showed cross-peaks with 8c 51.58, 51.65 and 51.92 respectively in the HMQC NMR 
spectrum.
The HMBC correlations between the methyl ester protons and their adjacent 
carbonyls allowed the assignments of their corresponding carbonyls. Similarly the 
HMBC correlations between the carbonyl groups and the 2 and 3 bond neighbouring 
protons helped to confirm their placement within the molecule. The 'H and 13C 
NMR spectral data of trimethyl nonane-1,2,3-tricarboxylate (2.1A) are summarized 
in Table 4.
Table 4 The *H and I3C NMR spectral data of trimethyl nonane-1,2,3-
tricarboxylate2.1A
No 8c 8h HMBC
1 174.25- C 3.61
2 33.26 - CH2 2a: 2.91
2b: 2.77 (dd, J4.3, 12.5)
3 43.24 -C H 3.43 (m)
4 46.52-C H 2.9 l(m)
5 29.10-CH2 5a: 1.49 (m) 
5b: 1.73 (m)
6 27.46 - CH2 6a: 1.23 (m) 
6b: 1.08 (m)
7 29.13-CH2 7a: 1.08 (m) 
7b: 1.08 (m)
8 31.56-CH2 8a: 1.08 (m) 
8b: 1.23 (m)
9 22.59 - CH2 9a: 1.08 (m) 
9b: 1.08 (m)
10 13.98-CH 3 0.72 (3H,t, J7.0)
11 172.28- C 3.52, 2.91, 
2.77
12 173.50-C 3.59, 1.49, 
1.73,3.43
13 51.92-OCH3 3.61 (s)
14 51.58-OCH3 3.52 (s)
15 51.65-OCH3 3.59 (s)
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2.2 Isolation and characterisation of spiculisporic acid (2.2)
The crude extract of A311R in addition to the previously described compound, also 
showed a brown spot near the base of the silica gel plate in the solvent system 
toluene : ethyl acetate : acetic acid (50:49:1), when sprayed with p-nitroaniline spray 
reagent. 1 g of the ethyl acetate extract was applied to preparative silica plates (5 x 
20 cm x 20 cm) to isolate this compound. Ethyl acetate : acetic acid (99:1) was used 
as the mobile phase to develop the plate. The brown spot moved further up to Rf 0.3. 
The band was then removed and washed with ethyl acetate to give a light brown 
solid, which was crystallised from nitromethane to give compound 2.2 as colourless 
crystals (28 mg), mp 142-145 “C, ESI [M-H]‘ m/z 327.1809, [a] ZD° - 12° (c 0.25, 
EtOH)
This compound gave a strong negative molecular ion at m/z 327 in the ESI mass 
spectrum, which did not appear to be consistent with the NMR data. The NMR data 
of 2.2 showed some similarities and differences with that of nonane-1,2,3- 
tr¡carboxylic acid (2.1). Initial analysis of the 13C NMR spectrum (C5D5N) (Figure 
23) suggested 12 signals, however the expansion of the area between 8c 28-31 
revealed four additional signals indicative of a molecule containing 16 carbon atoms, 
which was still inconsistent with mass spectrum negative molecular ion at 327.2. 
Further processing of the 13C NMR spectrum confirmed that the signal at 8C 29.69 
was in fact two signals overlapping each other. So the I3C, 'H, HMQC and DEPT135 
NMR spectra of 2.2 revealed a molecular formula C i7H2806, which requires a 
molecular ion at m/z 328 which matches the strong molecular ion at m/z 327 seen in 
the ESI negative mass spectrum.
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The 13C NMR spectrum (Figure 23, C5D5N) showed 3 carbonyl signals at 5c 174.52, 
175.12 and 176.82 similar to those found in 2.1, which suggested that this compound 
could be another tricarboxylic acid metabolite. The main differences in the 13C 
NMR spectra of 2.1 and 2.2 is the presence in 2.2 of signals at 5c 52.14 and 87.62 
instead of the signals at 5c 44.34 (C-3) and 47.42 (C-4) in the 2.1. These new down 
field signals indicate a strong deshielding effect resulting from the presence of an 
electronegative atom or a group such as a hydroxyl group. The presence of such a 
group needs a molecular ion of m/z 346, which is not seen in the mass spectrum. In 
the IR spectrum compound 2.2 showed absorptions typical of carboxylic acid 
hydroxyl groups and carbonyl groups at 2952, 2550, 1791, 1778 and 1710 cm'1. 
These groups were also observed as three carbonyl signals at 5c 174.52, 175.12 and 
176.82 in the 13C NMR spectrum. The absorption at 1791 cm'1 in the IR spectrum 
suggested the presence of a five ring lactone system 5 and led to a molecular formula 
ofCnH2806, which is in turn consistent with the negative molecular ion at m/z 327.
The ’H NMR spectrum of 2.2 (Figure 22, C5D5N) showed a prominent doublet of a 
doublet signal at 5 h  3.66 which showed a cross-peak with Sc 52.14 in the HMQC 
spectrum (Figure 25). In the ‘H-'H COSY spectrum (Figure 26), this signal is 
coupled to SH 2.33 and 1.93, which were further coupled to signals at 5H 1.68 and 
1.53. The last two protons showed further coupling to signals at 5h 1.14 and 1.22. 
This analysis of the coupling network in the 'H-'H COSY and HMQC NMR spectra 
allowed the establishment of the partial substructure 2.2a.
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3.66 2.33 1.68 1.14 1 07
Green arrows: ’H-'H COSY 
2.2a
Analysis of the HMBC and H2BC spectra (Figure 28) yielded further connectivities 
to the substructure 2.2a to give 2.2b.
Pink arrows: HMBC 
Blue arrows: H2BC
2.2b
In the HMBC spectrum (Figure 27), the signal at 5H 3.66 showed a cross-peak with 
5c 175.12, the signals at 5H 2.70 and 2.83 showed cross-peaks with the signals at 5c 
52.14,176.82 through 3 bonds and the signal at 5c 174.52 confirming the position of 
each carbonyl within the molecule.
The 'H NMR spectrum indicated one methyl group at 5H 0.77 which showed a cross­
peak with the signal at 5c 14.14 in the HMQC. The 'H-'H COSY spectrum showed 
this signal coupled to 5h 1.14 and 1.07. The last proton signal at Sh 1.07 in the 'H 
NMR spectrum showed an integration of approximately 9 protons. This made the
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assignment of connected carbons in the HMQC quite difficult especially between 5c 
28.48-29.69 where there are 8 carbon signals. The HMBC correlation between the 
methyl protons and the signal at 5c 30.12 was helpful in the assignment of the 
substructure 2.2c.
Green arrows: 'H-'H COSY 
Pink arrows: HMBC 
Blue arrows: H2BC
2.2c
Full analysis of ]H, l3C, HMQC, HMBC and H2BC spectrum (Table 5) led to the 
establishment of the final structure of 2.2 to be as shown by Figure 20.
o
Figure 20 Compound 2.2 structure
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Table 5 Full analysis of *H, 13C, HMQC, HMBC and H2BC NMR data of 2.2
run in pyridine (C5D5N)
8c SH H2BC H-H COSY HMBC
1 176.82-C 2.70,
2.83
2 28.75 - CH2 2.83, 2.83 (m)
3 31.92-CH2 2.70,2.83 (m) 1.93
4 87.63 -  C 2.70,
2.83, 3.66
5 52.14 -CH 3.66 dd (J 
10.77, 2.75)
2.33 2.33,1.93 2.33,2.83
6 28.74 - CH2 2.33, 1.93 (m) 3.66, 1.68, 1.53,3.66, 1.93,
1.53 2.70,
2.83, 3.66
7 28.48 - CH2 1.68, 1.53 (m) 1.22, 1.93, 
2.33
2.33, 1.93
8 29.39 - CH2 1.14, 1.22 (m) 1.14, 1.07
9 29.69 - CH2 1.07, 1.07 (m)
10 29.69 - CH2 1.07, 1.22 (m)
11 29.68 - CH2 1.07, 1.14 (m) 1.07
12 29.57 - CH2 1.07, 1.14 (m)
13 30.12-CH2 1.07, 1.14 (m) 1.07, 1.14 2.70,
2.70,
2.83, 3.66
14 22.76 - CH2 1.07, 1.07 (m) 0.77, 1.07, 
1.14
0.77, 1.07
15 14.14-CH3 0.77 (3H, td, J  
6.0, 2.3)
1.07
16 174.52-C 2.83, 3.66
17 175.12 -C 3.66
A literature search showed that this compound is known as spiculisporic acid. The
first isolation was by Clutterbuck et al from Penicillium spiculisporum in 19316. It
was also isolated from Penicillium crateriforme in addition to succinic acid by
Oxford et a l1. Fujimoto et al also isolated spiculisporic acid from an ascomycetous
fungus Talaromyces panasenkoi and they found it to be lethal to mice 8. Yutaka et al
investigated surface active properties of biosoap from spiculisporic acid to be used as 
0
biosurfactant .
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The total synthesis of spiculisporic acid has been described by Goodwin 10. He 
reported the synthesis of the two possible diastereomeric forms of spiculisporic acid 
shown in Figure 21.
(-)-Spiculisporic acid
(-)-Epi-Spiculisporic acid
Figure 21 The two diastereomers of spiculisporic acid
The two diastereomers showed some important differentiable IR, NMR spectral and 
optical rotation data. In the IR spectrum the epi-spiculisporic acid showed a lactone 
absorption at 1801 cm'1, while the other isomer showed two absorptions at 1793 and 
1778 cm'1 for the lactone ring. The other important differentiable spectroscopic data 
was in the ’H NMR data. The epi-spiculisporic acid showed H-5 at 8H 3.03 as a 
doublet of doublets (1H, J  = 9.3, 4.2 Hz), whilst the other isomer showed the same 
proton at 8h 3.01 also as a doublet of doublets (1H, J  = 10.8, 2.7 Hz). The reported 
optical rotation of the synthesised spiculisporic acid was [a] 2D5 -  10.2° (c 0.43,
EtOH) and [a] 2D5 -  6.3° (c 0.75, EtOH) for the Epi isomer. The natural product 
optical rotation was [a] 2D° -  15° ( EtOH) 7.
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By comparing the above spectroscopic data with that from the spiculisporic acid 
isolated from A311R endophytic fungi, it can be confirmed that the isolated acid is 
not the epi-isomer.
Spiculisporic acid was also studied as a Biosurfactant-based ultrafiltration system to 
remove metal ions (copper, zinc, cadmium, and nickel) from metal ion mixtures as 
well as a single metal component solution u .
57
8.
65
51
00
C
hapter 2
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2.2.1 Formation of dimethyl ester of spiculisporic acid
Méthylation of spiculisporic acid 2.2 with diazomethane resulted in the formation of 
a dimethyl ester 2.2A. The latter, a waxy material, gave a weak molecular ion in the 
ESI mass spectrum at 355 and a strong signal for [M - CH3]' at m/z 341. The IR 
spectrum of 2.2A showed absorptions at 1740 and 1714 cm' 1 for ester carbonyl 
stretching and at 1764 cm' 1 for the 5 ring lactone system. The weak broad absorption 
at 2550 cm'1, which was seen in the IR spectrum of 2.2, is absent.
Comparison of the NMR spectral data of 2.2 and 2.2A proves the presence of two 
carboxylic acid groups in 2.2. The ]H NMR spectrum of 2.2A (Figure 30) showed 
two extra methyl groups at SH 3.63, and 3.67, which in turn showed cross-peaks with 
5c 51.85 and 51.88 in the HMQC NMR spectrum, due to the formation of two 
methoxy groups when 2.2 reacts with diazomethane. Table 6 shows the 'H and 13C 
NMR data of both 2.2 and 2.2A.
The 13C NMR spectrum of 2.2A (Figure 31) showed three carbonyls at 8c 171.53, 
172.54 and 175.68. The first two are shifted by 3 ppm to higher field compared to 
their corresponding carbonyls in 2.2 while the one at 8c 175.68 does not show this 
known shift that occurs when a carboxylic carbonyl group is methylated. This is 
evidence that this carbonyl group wasn’t a carboxylic acid type and that compound
2.2 contains only two carboxylic acids plus a lactone carbonyl group as shown by 
Figure 29 . After esterification the IR spectrum showed main absorptions at 1740 
and 1764 cm' 1 with the disappearances of the carboxylic hydrogen bonding 
absorption at 2550 cm'1.
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Table 6  *H and 13C NMR data of both 2.2 and 2.2 A.
2.2 2.2.A
5c 5 h # 8c 5 h
176.82- C 1 175.68-C O O  Me
28.75 - CH2 2.83,2.83 (m) 2 27.99 - CH2 1.18, 1.11 (m)
31.92-CH2 2.70,2.34 (m) 3 31.94-CH2 2.67, 2.58 (m)
87.63- C 4 86.52- C
52.14 -C H 3.66 (dd) 5 52.88-C H 3.26 (dd)
28.74 - CH2 1.68,1.53 (m) 6 27.95 - CH2 1.65, 1.34 (m)
28.48 - CH2 2.33,1.93 (m) 7 27.92 - CH2 1.26, 1.18 (m)
29. 39 - CH2 1.14, 1.22 (m) 8 29. 37- CH2 1.11, 1.11 (m)
29.69 - CH2 1.07,1.07 (m) 9 29.56 - CH2 1.11, 1.11 (m)
29.69 - CH2 1.07,1.22 (m) 10 29.64 - CH2 1.11,1.18 (m)
29.68 - CH2 1.07,1.14 (m) 11 29.43 - CH2 1.11, 1.18 (m)
29.57 - CH2 1.07,1.14 (m) 12 29.40 - CH2 2.56, 2.56 (m)
30.12-CH2 1.07,1.14 (m) 13 29.64 - CH2 1.11, 1.11 (m)
22.76 - CH2 1.07,1.07 (m) 14 22.77 - CH2 1.11, 1.11 (m)
14.14-CH3 0.77 (td) 15 14.13-CH 3 0.78 (td)
174.52- C 16 171.53 - C
175.12 — C 17 172.54- C 3.67 (s)
18 51.85-OMe
19 51.88-OMe 3.63 (s)
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Figure 30 *H NMR spectrum (C5D5N) of 2.2A
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C h a p te r  3: S econdary  m etabo lites from  X.6RD12 
3.0 6RD12 fungus overview
The fungus coded 6RD12 was isolated from palm trees in Thailand. It was received 
in Petri dishes as shown in Figure 32. The front view of the Petri dish showed white 
mycelium with black circular areas. The reverse side of the fungus was orange.
Figure 32 Fungi 6RD12 as received from Thailand
The fungus was sub-cultured into master tubes and 5 conical flasks (250 ml) 
containing the aqueous malt extract-glucose mixture. The conical flasks were kept 
under observation for 3 weeks (Figure 33).
Figure 33 Fungus 6RD12 in flask after 3 weeks
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The fungus developed black cylindrical stromata with white tips after 2 weeks. The 
fungus was then cultured in Thompson bottles for 8 weeks. The fungus during the 
first 4 weeks grew as white mycelium and then developed black areas.
The mature cultures were harvested and the mycelium recovered by filtration 
through a muslin cloth. The aqueous filtrate was extracted with ethyl acetate in a 5.0 
L separating funnel. The ethyl acetate fraction was dried over anhydrous sodium 
sulphate. After removal of the solvent 3.35 g of crude extract was obtained.
3.1 Isolation and structure elucidation of 4,5,6-trihydroxy-3-propyl- 
3,4,6,7-tetrahydro-lH-isochromen-8(5H)-one (3.1)
The normal phase TLC analysis of the ethyl acetate extract eluted with toluene, ethyl
acetate and acetic acid (50:49:1) showed only a dark brown spot at the origin of the
TLC. As a result, a reverse phase TLC was used, which showed 3 weak UV active
spots at Rf 0.96, 0.85 and 0.46. Sephadex LH-20 (70 g) in a chromatography column
(50 x 2 cm) was used to separate the components of the ethyl acetate crude extract (3
g)-
Methanol-water (80:20) mobile system was used to elute the column. The first 
compound (3.1) collected was white solid (95 mg), mp 180-185 °C, HRESIMS 
[M+H]+ mfz 243.12274; [a]2Q2 - 160° (c 0.5, MeOH); IR<Ara) vmax cm’1 : 3378, 1673 
and 1105. The main IR absorptions suggested presence of hydroxyl and carbonyl 
groups.
HREIMS analysis of (3.1) gave a molecular ion at [M+H]+ m/z 243.12274, which 
gives a molecular formula of C12H18O5. The 'H NMR spectrum (Figure 36) run in 
(C5D5N) revealed one methyl at 5h 0.82 (3H, t, 7  7.4 Hz), and methylene protons at 
5h 1.43 (1H, m), 1.62, (2H, m), 2.04 (IH, m),2.81 (IH, dd, J3 .6 , 15.81Hz), 3.21
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(1H, dd, J 8.1,15.81), 4.77 (1H, m) and 4.42 (1H, dt, J  16.3, 2.4); methine protons 
at 8h 3.65 (1H, td, J2.75, 8.1 Hz), 4.75 (1H, m), 5.42 (1H, bs) and 4.51 (1H, m).
The 13C and DEPT 135 NMR spectra (Figure 37 and Figure 38, C5D5N) of 
compound 3.1 revealed 12 carbons: one methyl at 8c 14.17, four methylene at 8c 
18.98, 34.91, 43.50 and 63.48, four methine 8c 66.48, 66.82, 69.59, 79.08 and three 
quaternary carbons 8c 132.60, 155.27 and 197.08. The prominence of the M-18 peak 
(m/z 225 and 207) in the EIMS spectra of 3.1 suggested the presence of hydroxyl 
groups. The molecular formula suggested a total of four degrees of unsaturation.
The l3C, 'H, HMQC, DEPT135, 'H-'H Cosy, HMBC and H2BC NMR spectra 
allowed the assignment of all the protons and their connectivities and identification 
of the associated carbon signals.
Evaluation of the 2D DQF-COSY spectrum (Figure 39) allowed the identification of 
the spin systems. The methyl protons at 8h 0.82 are coupled to the methylene protons 
at Sh 1.42 and 1.62 [showed cross peak with 8c 18.98 in the HMQC spectrum 
(Figure 40)], which were in turn coupled to the methine proton at 8h 3.65. This 
sequence of the proton coupling led to the establishment of a partial sub-structure 
3.1a.
Partial structure 3.1a showing 'H-'H connectivities
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This spin system was refined further through interpretation of a H2BC spectrum 
(Figure 42), which can be described as follows; the methylene carbon observed at 8c 
18.98 correlates to the methyl proton at 8h 0.82 and to the methylene protons at 5h 
1.62. The last in turn correlates to the methine carbon at 8c 79.08.
3.65 1.62 1.43
Partial structure 3.1a showing H2BC correlations (Blue arrows)
This partial structure was also supported by the HMBC experiment (Figure 41), 
which showed correlations between the proton at 8h 3.65 and the carbon at 8c 18.98. 
The chemical shift of 8c 79.08 suggests a carbon attached to oxygen. The H2BC 
spectrum showed correlation between 8c 79.08 and 8h 4.75, which has a cross peak 
with 8c 66.82 (good indication of a secondary alcohol) in the HMQC spectrum 
confirming that those two carbons are neighbours to each other. Furthermore, the 
presence of coupling between the two protons at 8h 3.65 and 4.75 confirms the 
neighbourhood of these atoms.
Further HMBC correlations were observed between 8C 79.08 and 8H 4.77, which has 
a cross peak with 8c 63.76 in the HMQC spectrum. This carbon in turn showed an 
HMBC correlation with the methine proton at 8h 3.65. This information led to the 
sub-structure 3.1b as shown below.
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4.42 4.77
Table 7 summarises ID and 2D NMR data (C5D5N) 
Table 7 ID and 2D NMR data of 3.1 (C5D5N).
No 8c 8h HMBC H-H COSY H2BC
1 14.17-C H 3 0.82 (t, 77.4) 2(1.43) 2 2
2 18.98-CH2 1.62, 1.43 (m) 1,9 3,3,1 1
3 34.91 -C H 2 2.04, 1.62 (m) 1,2(1.43) 9,2 2,2 ,9
4 43.50-C H 2 2.81 (dd ,73 .6 ,12.18) 4,8 8
3.21 (dd, 78.1,7.74)
5 63.76 -  CH2 4.42 (dt, 7  16.3, 2.4) 9 5
4.77 (m)
6 66.48-C H 5.42 (bs) 4,4 8
7 66.82-C H 4.75 (m) 9 9 9,6
8 69.59-C H 4.51 (m) 4 4, 4,6 6,4
9 79.08 -  CH 3.65 (td, 72.75, 8.1) 7 7,3 3,7
10 132.60- C 5,5
11 155.27- C 7,8
12 197.08- C 4,4
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The observation of more HMBC correlations between the methylene protons 
resonating at 8h 4.77 and 4.42, which are connected to 5c 63.76 and the carbon 
signal at 5c 132.60 allowed the placement of the double bond within the sub­
structure 3.1b. The presence of an HMBC correlation between the proton at 8h 4.75 
and the carbon signal at 8c 155.27 allowed for closure of the six ring to give sub­
structure 3.1c.
Another sub-structure unit was established by tracking the rest of the correlations in 
the 'H-'H COSY and HMBC spectra. In the rH-'H COSY the methylene protons at 
5h 2.81 and 3.21, which show a cross peak with 5c 43.50, both showing correlation 
to 8h 4.51, which shows a cross peak at 8c 69.59, which in turn couples to 8h 5.42 to 
give the partial sub-structure 3.1d.
3.1d
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The spin system 3.1d was further confirmed through interpretation of the HMBC and 
H2BC NMR data. In the HMBC spectrum, the protons at 5h 2.81 and 3.21 showed 
correlations with the carbon at 8c 66.48. The same protons showed H2BC 
correlations with the 8c 69.59, which showed another correlation to the proton at 8h 
5.42 confirming the positions of the neighbouring atoms as shown by partial 
structure 3.1e.
3.21
H
Pink: HMBC 
Blue: H2BC
5.42 ’ ' OH
3.1e
More HMBC correlations were observed between the protons at 8h 2.81 and 3.21
and the carbon at 8c 197.08 allowed the addition of a carbonyl group to the above
substructure. The HMBC correlation between the proton at 8H 4.51, which is
connected to 8C 69.59, and the double bond carbon at 8c 155.27 helped to connect
sub-structure 3.1c with sub-structure 3.1e to give 3.1f:
o
So the final structure of compound 3.1 is suggested to be as shown by Figure 34.
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Figure 34 Structure of 3.1
A Scifinder search revealed that compound 3.1, 4,5,6-trihydroxy-3-propyl-3,4,6,7- 
tetrahydro-l//-isochromen-8(5//)-one has not been reported previously either from a 
synthetic or a natural product source. Table 8 summarises the NMR data according 
to Figure 34.
Table 8 NMR data (C5D5N) of 4,5,6-trihydroxy-3-propyl-3,4,6,7-tetrahydro- 
l//-isochromen-8(5//)-one (3.1)
No Sc Sh
1 63.76 -  CH2 4.42 (dt, J  16.3, 2.4), 4.77 
(m)
3 79.08-C H 3.65 (td, J2.75, 8.1)
4 66.82 -  CH 4.75 (m)
5 66.48-C H 5.42 (bs)
6 69.59-C H 4.51 (m)
7 43.50 -C H 2 2.81 (dd,J3.6, 15.81) 
3.21 (dd,7 8.1, 15.81)
8 197.08 - C
9 132.60- C
10 155.27- C
11 34.91-C H 2 2.04, 1.62 (m)
12 18.98-C H 2 1.62,1.43 (m)
13 14.17-C H 3 0.82 ( t ,J  7.4)
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3.1.1 Stereochemistry of 4,5,6-trihydroxy-3-propyl-3,4,6,7-tetrahydro-lH- 
isochromen-8(5H)-one (3.1)
Having established the structure of compound 3.1, the next challenge was to resolve 
the stereochemical relationships of the three hydroxyl groups and the «-propyl side 
chain. This proved a particular challenge. Ideally the way forward was to use XRD, 
but unfortunately a suitable crystal could not be grown.
It did not prove feasible to analyse the *H NMR spectrum of 3.1 in C5D5N to 
determine coupling constants, which could be used in conjunction with the Karplus 
Equation *, to determine dihedral angles between adjacent substituents. Most of the 
signals of interest in the 5h 3.5 to 5.5 region of the spectrum are poorly resolved due 
to coupling between most of the protons of interest and the protons of the hydroxyl 
groups (Figure 36).
This problem was resolved by adding a drop of deuterium oxide to the sample in 
C5D5N and re-acquiring the 'H N M R  data with the probe temperature increased to 
30 °C. This resulted in a spectrum with much improved resolution in the 8h 3.5 to
4.8 region of the spectrum (Figure 43) and the appearance of signals with clearly 
defined multiplicities. The only down side was due to the HOD signal masking the 
signal at 8h 5.42 from the methine proton on C-5. A complete analysis of the new !H 
N M R  spectrum is presented in Table 9 .
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Table 9 !H NMR data for Compound 3.1 plus D2O in C5D5N at 30 °C 
Carbon No 8 h
Chapter 3
1 4.35 (1H, d , J  16.32 Hz)
4.66 (1H, d , J  16.32 Hz)
3 3.61 (1H, dt, J8.16, 2.58 Hz)
4 4.71 (1H, d, .77.56 Hz)
5 5.38 (1H, bs, LHS edge HOD peak)
6 4.48 (1H, ddd, J  8.33, 3.61, 3.52 Hz)
7 3.17 ( lH ,d d ,J  15.98, 8.42 Hz)
2.76 (1H, dd, J  15.98, 3.69 Hz)
11 1.59 (1H, m)
1.97 (lH ,m )
12 1.39 (1H, m)
1.53 (1H, m)
13 0.79 (3H,t, J  7.30 Hz)
The magnetically non-equivalent methylene protons on C-7 show well-defined 
doublet of doublet signals at 5H 2.76 and 3.17 with J  values of 15.98, 8.42 and 3.69 
Hz. Clearly the 15.98 Hz coupling is due to geminal coupling of the methylene 
protons. The remaining J  values relate to coupling to the methine proton on C-6 at 
8h 4.48. Examination of the J  values associated with the latter gives 8.33, 3.61 and 
3.52. The values of 8.33 and 3.61 essentially match with those of 8.42 and 3.69 
associated with the protons on C-7. This leaves a coupling constant of 3.52 Hz for 
the coupling to the methine proton on C-5, which in turn means a dihedral angle 
between the protons on C-6 and C-5 of 60° typical of an equatorial- equatorial 
relationship, thus the OH groups must be in an anti relationship to each other.
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Turning attention to the other ring, the methine proton on C-4 appears as a doublet at 
5h 4.71 with J  coupling of 7.56 Hz to the methine proton on C-3. This suggests that 
the H-3, H-4 protons have an anti relationship and that the «-propyl and the hydroxyl 
groups are in an equatorial-equatorial relationship.
A series of phase sensitive 2D NOESY experiments with variations in the mixing 
time of 0.1s in the range 0.4 to 0.8s failed to detect any cross peak between the 
protons on H-4 and H-5 indicative of a tram  relationship.
Putting all of this information together suggested that the 3-dimensional structure of 
compound 3.1 was as shown by Figure 35.
H
OH
n-Pr
H
O
OH OH
Figure 35 Relative stereochemistry of compound 3.1
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3.1.2 Antiplasmodial test of 3.1
Compound 3.1 was tested for antiplasmodial activity against Plasmodium falciparum 
strain Kl. The test was done in The Bradford School of Pharmacy, University of 
Bradford by the research group of Dr Colin W. Wright. It gave IC 50 = 3.74 pg/mL 
(mean of two experiments).
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Figure 36 ’H NMR spectrum (C5D5N) of 3.1
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Figure 38 DEPT 135 spectrum of 3.1
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Figure 41 HMBC NMR spectrum of 3.1
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Figure 43 Zoomed !H NMR spectrum (C5D5N + drop of D2O) of the region at 8h (2.8 -  4.8) of comound 3.1
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3.2 Isolation and structu re  elucidation of cycloepoxydon 3.2
The second compound (3.2) collected from the column described is section 3.1 was a 
white solid (17.4 mg). Recrystallisation from nitromethane to gave colourless 
crystals (7.3 mg ), mp 186-189 °C, ES [M+H]+ m/z 241; [a]zD2 - 139° (c 0.25,
CHCl3:MeOH (95:5)); IR(atr) vmax cm*1 : 3378, 1673 and. The main IR absorptions 
suggested the presence of hydroxyl and carbonyl groups.
The 'l l  NMR spectrum [(CD3)2CO, Figure 48] of this compound showed 14 protons 
at 5H 0.89 (3H, t, J 1 2  Hz), 1.36 (1H, m), 1.38 (1H, m), 1.41(1H, m), 1.79 (1H, 
m,), 3.19 (td, J 8.4, 2.6, Hz ), 3.34 (1H, d, J4.1 Hz), 3.85 (1H, t, J3.95), 4.12 (1H, 
t, J1.96 Hz), 4.15 (2H, m,), and 4.95 (1H, bs).
The 13C and DEPT-135 NMR spectra [(CD3)2CO, Figure 49] of compound 3.2 
revealed a 12 carbon skeleton structure containing: one methyl at 6c 13.52, three 
methylene at 8c 18.49, 34.40, 63.29, five methine carbons 8c 53.21, 55.12, 63.63, 
66.76, 78.27 and three quaternary carbons at 8c 128.49, 151.79 and 192.73. The 13C 
NMR and the mass spectral data suggest that this compound is similar in structure to 
compound 3.1 with a molecular formula of Ci2Hi60 5. The main NMR differences in 
the 13C NMR spectrum of compound 3.1 and 3.2 (Table 10) is the replacement of a 
methylene signal at 8c 43.50 in 3.1 by a methine signal at 8C 54.08 in 3.2. The other 
main NMR difference is an up field shift of a methine signal to 8c 56.55 in 3.2, 
whilst all the methine signals resonate at 8C > 65 in compound 3.1. The molecular 
formula CnH^Os indicates five degrees of unsaturation, which means one more 
degree of unsaturation compared to compound 3.1. This information suggested the 
structure of compound 3.2 to be as shown in Figure 44
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O
Figure 44 Suggested structure of 3.2
Table 10 13C NMR data of 3.1 and 3.2 run in pyridine-d5 (C5D5N)
3.1  NM R DATA 3.2  NM R D ATA
No Sc Sc
1 63.76-CH 2 63.74-CH 2
3 79.08-CH 78.27-CH
4 66.82-CH 66.68-CH
5 66.48-CH 63.81 -  CH
6 69.59-CH 56.55-CH
7 43.50-CH 2 54.08-CH
8 197.08-C 193.32-C
9 132.60-C 129.06-C
10 155.27-C 154.02-C
11 34.91-CH 2 34.75 -  CH2
12 18.98-CH2 18.87-CH2
13 14.17 -CH3 14.11-CHj
A series of 2D NMR experiments were run in acetone-d6 to confirm the structure. 
The proposed structure was supported by the HMBC experiment (Figure 52), which 
showed correlations between the proton at SH 3.19 and the carbon at 5c 18.87. The 
low field chemical shift of 5c 78.27 indicates the electronegative effect of the
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neighbouring oxygen. Furthermore, an observation of 'H-'H coupling (Figure 51) 
between the two protons at 8h 1.38 and 4.15 with that at 8h 3.19 confirms the 
neighbourhood of these atoms and the placement of each one.
Further HMBC correlations were observed between 8c 78.27 and 8h 4.12, which has 
a cross peak with 8c 63.29 in the HMQC spectrum (Figure 50). This carbon in turn 
showed an HMBC correlation with the methine proton at SH 3.19.
The observation of more HMBC correlations between the methylene protons at 8h 
4.15 and 4.12, which are connected to 8c 63.29 and the carbon signals at 8c 132.60 
and 151.79 allowed the placement of the double bond within the structure as shown 
by Figure 45
o
Green arrows: 'H-'H COSY 
Pink arrows: HMBC
Figure 45 Partial HMBC and ^ - ’H COSY correlation of 3.2
By tracking the rest of the spin system in the 'H-'H COSY and HMBC spectra the 
whole structure was confirmed. In the 'H-’H COSY the methine proton at 8H 3.34 (d, 
J  4.1), which showed a cross peak with 8c 53.21 in the HMQC spectrum, showed 
coupling with 8h 3.85 (t, J  4.0), which in turn coupled to SH 4.95 (bs) as shown in 
Figure 46. While in the HMBC spectrum, the protons at 8H 3.85 and 4.15 showed 
correlation with the carbon at 8c 151.79. The proton at 8h 3.34 showed correlations
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with the carbon at 8c 128.49 and 192.73. All these correlations are presented in 
Figure 46 and Table 11
Green arrows: 'H-'H COSY 
Pink arrows: HMBC
Figure 46 The rest of HMBC and 'H-'H COSY correlation of 3.2
Table 11 II) and 21) NMR data for 3.2 run in acetone (Cl)3)2CO
No 5( 6ii HMBC H-H COSY
1 63.29-Cll2 4.12 (dt, J  16.32, 
1.96), 4.15(m)
34.40, 192.73, 78.27 4.15
3 78.27-CH 3.19 (td J 2.6, 8.4) 66.76, 63.29, 34.40, 
18.49
1.38
4 66.76-CH 4.15 (m) 151.79, 128.49, 34.40 3.19
5 63.63- CH 4.95 (bs) 151.79 4.15,3.85,:
6 55.12-CH 3.85 (t, .73.95) 151.79, 63,63 3.34, 4.95
7 53.21- CH 3.34 (d, .74.1) 192.73, 128.49 3.85
8 192.73- C
9 128.49-C 3.34
10 151.79-C
11 34.40- CH2 1.38 (m), 1.79 (m) 1.41
12 18.49- CH2 1.36 (m), 1.41 (m) 0.89
13 13.52-CH3 0.89 (3H, t, .7 7.2)
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A literature review revealed, that this compound was isolated for the first time in 
1997 by Gehrt et al from fermentations of a Deuteromycete strain in addition to 1- 
hydroxy-2-hydroxymethyl-3-pent-l-enylbenzene and 1 -hydroxy-2-hydroxymethyl- 
3-pent-l,3-dienylbenzene '. It was given the name cycloepoxydon. The relative 
stereochemistry of (-)-cycloepoxydon was determined by the NOESY correlations, 
and by analysis of the 'H«'!! coupling constants. By comparing the reported 'H"'!! 
coupling constants with that observed for the isolated compound, it was confirmed 
that both have the same relative stereochemistry, which means that the isolated 
compound has the structure shown by Figure 47.
O
Figure 47 The relative stereochemistry of (-)-cycloepoxydon
Interestingly cycloepoxydon has the same relative stereochemical relationship for the 
ring substituents as was reported in the previous section for 4,5,6-trihydroxy-3- 
propyl-3,4,6,7-tetrahydro-l//-isochromen-8(5//)-one (3.1). This suggests that 
cylcoepoxydon may be the parent compound of compound 3.1, or vice-versa.
Cycloepoxydon was found to be a bioactive inhibitor of eukaryotic signal 
transduction and can be a candidate for antitumor drugs, especially against breast 
cancer 2‘3. The total synthesis of this compound was also reported 4'5.
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So this is the second report for the isolation of cycloepoxydon from a natural source, 
and the first report for the isolation of this compound from an endophytic xylaria 
fungus. This fungus was re-cultured twice to test the stability of its metabolite 
production. In both cases the fungus produced the same metabolites. The mycelium 
was examined for its content, and it was found to contain the same metabolites as 
well as the culture medium.
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C h a p te r  4 S econdary  m etabo lites from  X. A 217R  an d  A 517R 
4.0 Fungi A217R and A517R overview
The fungi coded A217R and A517R are endophytes extracted from palm trees 
(Arenga pinnata (Sugar Palm)) from Kao Loung National Park in Thailand. They 
were received in Petri dishes. They looked similar to each other from back and front 
views of the Petri dishes as shown in Figure 53.
A217R back view A217R front view
A517R back view A517R A217R front view
Figure 53 A217 R and A517 R in Petri dishes.
Both fungi were sub-cultured in conical tlasks containing aqueous 3% malt extract to 
prepare them for large scale culturing. After 3 weeks the conical flask containing
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A217R was showing stromata with a black base and a white tip, whilst A517R 
showed flower-like stamen stromata as shown in Figure 54.
Each fungus was cultured in six Thomson bottles (2L) in aqueous 3% malt extract 
enriched with 6% glucose for eight weeks; each bottle containing 1 litre of culture 
medium.
A217R conical flask A517R conical flask
Figure 54 Fungi A217R and A517R in conical flasks after 3 weeks
The mature fungi formed white gelatine-like myceliums ( Figure 55). The mycelium 
was removed by filtration through a muslin cloth and the aqueous filtrate extracted 
with ethyl acetate (3 x 700 ml) in a 5 L separating funnel. The extract was dried with 
sodium sulphate for 30 min. and the ethyl acetate was removed on a rotary 
evaporator to give a brownish gummy material (A217R 5.5 g and A517R 6.2 g).
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Figure 55 Mycelium of Fungus A517R
The extracts were then analyzed for their content by TLC. A solvent system of 
toluene: ethyl acetate: acetic acid (50:49:1) was used as eluent. Both extracts showed 
matching patterns of spots under visible and UV light. Under visible light, a violet 
coloured spot appeared at Rf of 0.58. Under short wave UV (245 nm), three UV 
active spots were detected; a weaker spot at the lower Rf 0.27 and two stronger spots 
at 0.65 and 0.90.
When the TLC plates were sprayed with />nitroaniline the two upper UV active 
bands (Rf 0.65 and 0.90) developed a strong orange colour spots and an opaque spot 
at Rr 0.27.
Comparison of the spots patterns of both A217R and A517R. suggested that both 
extracts were from very similar fungi species that produce similar secondary 
metabolites.
4.1 Isolation of Cytochalasin D from fungus A217R
The ethyl acetate extract was triturated with ethyl acetate and left overnight. A white 
precipitate was obtained. The white solid compound was filtered off and
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recrystallized from ethyl acetate to give white needles (65 mg), mp 238-240 °C, ES 
[M+H]+ m/z 508. This compound showed an opaque spot when treated with 
diazotised /Miitroaniline spray reagent at Rf. 0.27 on the TLC. This compound was 
also isolated by preparative TLC run with a solvent system of toluene: ethyl acetate: 
acetic acid (50:49:1) by recovery of the band at Rf 0.27.
The IR spectrum (Figure 56) of this compound shows the following distinguishable 
signals: 3681, 3405, 2919, 1739 and 1689 cm’1, which can indicate the presence of 
the followings: an amide group, a carbonyl ester group, and a hydroxyl.
'H NMR spectrum (C5D5N) of this compound (Figure 58) gave 4 methyl protons at 
8h 0.77 (d, J  6.70 Hz), 0.98 (d, J  6.50 Hz), 1.50 (s) and 2.33 (s). it also revealed 3 
methylene protons at 5h 1.93 (dd, J  5.0, 11.8 Hz), 2.86 (m), 5.41 (s) and methyne 
protons at SH 2.42 (m), 2.66 (m), 2.97 (m) 3.38 (t, J  10.5 Hz), 3.55 (m), 4.39 (d,
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J=10.1 Hz), 5.60 (m), 5.57 (m), 6.01 (d, J  15.5), 6.34 (m), 6.84 (dd, J2.23, 15.8 Hz), 
7.14 (m) and 7.24 (m).
The protons at 5h 7 region indicated the presence of a phenyl ring, whilst the shifts 
between 6h 5.5 and 6.5 indicated possible alkene protons with adjacent protonated 
carbons, based on the splitting patterns. The singlet peaks at Sh 5.05 and 5.41 did not 
show any correlations in the 'H-'H COSY spectrum except with each other; they 
were therefore recognised as peaks from a terminal alkene carbon linked to a non- 
protonated carbon.
The 13C (Figure 59), DEPT-135 and DEPT-90 NMR spectrum run in (C5D5N) of this 
compound presents 28 carbon signals. The signals at 5c 128.79 and 129.90 are 
double the height of other peaks signifying that these signals are each due to two 
carbon atoms, to give a total of 30 carbons. There are four methyl signals at Sc 
13.59, 19.34, 24.61 and 20.51, three methylene signals at 8C 45.49, 112.17 and 
38.54, seven quaternary signals at Sc 210.88, 175.11, 170.47, 151.63, 138.44, 78.39, 
and 53.99, plus 17 signals due to methyne carbons; seven methine signals in the 
olefmic/aromatic region between 8C 126-134 and nine further methine carbon signals 
in the region of 8C13-80.
The spectral and physical data of this compound suggested this compound was a 
cytochalasin, which are commonly formed as secondary metabolites by Xylariaceous 
fungi. The comparison of this 'H and 13C NMR data with the reported NMR data for 
a series of cytochalasins revealed that this compound is cytochalasin D (C30H37NO6, 
Figure 57). The proton signal observed at SH 9.10 and the methylene signal in the 
DEPT 135 spectrum at Sc 112.17, which showed a cross peak to Sh 5.05 and 5.41 in 
the HMQC, are indicative of cytochalasin D (Figure 57).
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The chemical shift of the N-H proton of the lactam ring in cytochalasin compounds 
appears generally above 8H 9.0, when pyridine-d5 is used as the NMR solvent. It has 
been observed that the signal for this proton can be characteristic for cytochalasin 
(Table 12). In cytochalasin D for instance, the N-H proton resonates at 8H 9.10, 
which is the case for the isolated cytochalasin.
Table 12 Characteristic physical data of some cytochalasins 1.
Cytochalasin Amide 0H in pyridine m p °C m /z
C 9.38 260-265 507
19,20-epoxycytochalasin C 9.46 245-247 523
D 9.13 267-270 507
N 9.55 272 523
O 9.25 258-265 525
P 9.10 169-173 525
Q 9.45 145-147 507
R 9.7 159-167 523
ID and 2D NMR experiments were used for the C-H assignments. Data from *H 
NMR, 13C, DEPT, and HMQC of this cytochalasin are presented in (Table 13).
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Cytochalasin D was reported for the first time as a metabolite of Metarrhizium 
anisopliae 2. Its structure determination using chemical methods was reported in 
1969 3. From that time it is known as a common secondary metabolite produced by 
fungi. It possesses antibiotic 4 and antitumor5 activities. It also weakens maintenance 
of long term potentiation (LTP) of actin filaments 6.
108
Chapter 4
Table 13 'H NMR, 13C, DEPT, and HMQC (C5D5N) of cytochalasin D
NO 5c DEPT 8h (mult)
1. 175.11 C
2. NH 9.10
3. 54.36 CH 3.55 m
4. 50.07 CH 2.42 m
5. 33.14 CH 2.97 m
6. 151.63 C
7. 71.27 CH 4.39 d ( J  10.1)
8. 47.87 CH 3.38 t ( J  10.5)
9. 53.99 C
10. 45.49 c h 2 2.86 m
11. 13.59 c h 3 0.77 d ( J  6.70)
12. 112.17 c h 2 5.05, 5.41 s
13. 126.79 CH 5.60 m
14. 132.80 CH 5.57 m
15. 38.54 c h 2 1.93 dd ( J 5.0, 11.8)
16. 42.43 CH 2.66 m
17. 210.88 C
18. 78.39 C
19. 133.82 CH 6.34 d
20. 132.95 CH 6.84 dd (J2 .2 3 ,15.8)
21. 77.99 CH 6.01 d (J  15.5)
22. 19.34 CH3 0.98 d (J 6.5)
23. 24.61 c h 3 1.50 s
24. 170.47 c
25. 20.51 c h 3 2.33 s
26. 138.44 C
27. 129.90 CH 7.24 m
28. 128.79 CH 7.14 m
29. 127.84 CH 7.22 m
30. 128.79 CH 7.14 m
31. 129.90 CH 7.24 m
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Figure 58 !H NMR spectrum of cytochalasin D in C5D5N 
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4.2 Isolation of Mellein from fungus A217R
After the isolation of cytochalasin D, the remaining ethyl acetate crude extract 
obtained from the fungus A217R (4.0 g) was triturated with warmed toluene to give 
a yellow oily fraction (1.1 g). This fraction showed 2 main compounds at at Rf 0.9 
and 0.65 The resultant yellow oily extract was subjected to preparative TLC (8 
plates 20x20 cm, GF254 silica gel), eluted with toluene: ethyl acetate: acetic acid 
(50:49:1).
The UV active band at Rf 0.90 developed a strong orange colour, when sprayed with 
diazotised p-nitroaniline spray reagent suggesting a phenolic compound. The band 
was recovered and washed with ethyl acetate to produce yellow solution. Removing 
the solvent gave pale yellow oil (34 mg). Trituration of the yellow oil with «-hexane 
gave a white solid (7.5 mg), which was recrystallised from the same solvent to give 
white plates (4.0 mg), mp 53-55 °C, ES [M+H]+ m/z 179, [a] 2D3 + 85° (c 0.05,
MeOH); IR<atr) vmax cm' 1 3187, 2997, 1662, 1614 and 1198. The IR absorptions 
suggested the presence of a hydroxyl and carbonyl groups.
The *H NMR (CDCI3, Figure 62) shows ten proton signals at 8H 1.54 (3H, d, J6.27 
Hz), 2.96 (2H, d, J  7.13 Hz), 4.74 (1H, m, J  8.09, 6.42), 6.72 (1H, d, J  7.39, Hz), 
6.91 (1H, d ,J  8.51 Hz), 7.44 (1H, dd.J7.39 and 8.42 Hz), 11.03 (1H, s).
In the 13C NMR spectrum (CDCI3, Figure 63) ten carbon signals comprise a methyl 
carbon at 8C 20.80, a methylene at 34.62, four methine carbons at 76.15, 116.23, 
117.95, and 136.19, and four quaternaries at 108.29, 139.34, 162.17, and 170.0. 
From the mass spectrum, *H and 13C NMR, the molecular formula was deduced to 
be C10H10O3.
1 1 2
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In the 'H-'H COSY spectrum, the doublet methyl proton at 8h 1.54, which correlates 
to 5c 20.80 in the HMQC spectrum, showed coupling to a methine proton at 6h 4.74, 
which correlates to 8c 76.15 in the HMQC. The down field carbon signal at 5c 
76.15 suggested an adjacent oxygen atom. The methine proton at 5h 4.74 also 
coupled to the methylene protons at 8h 2.96 which showed a cross peak with 8c 
34.62 in the HMQC spectrum. This gives a partial structure X.
X
The three protons in the aromatic region at, 7.44, 6.91 and 6.72 suggested a phenolic 
ring supported by the orange spot given by the compound, when sprayed with 
diazotised p-nitroaniline spray reagent in the TLC. Also six aromatic carbons were 
detected at 8c 108.29, 116.23,117.95, 136.19,139.43 and 162.17, three of which are 
quaternary carbons according to the DEPT135 analysis; suggesting a 1,2,3- 
trisubstitued benzene ring; partial structure Y.
O H
Y
The singlet proton at 5h 10.96 is a characteristic signal of a chelated -OH group. The 
carbon signal at 8C 170.00 suggested an ester carbonyl carbon. According to the low
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infra-red absorption at 1662 cm-1 a chelated lactone system was likely. Combining 
the two substructures gave the structure of mellein (Figure 60).
ll
OH O
Figure 60 Structure of mellein
The NMR data of the compound were established unambiguously using ID and 2D 
NMR spectral experiments, 'H, 13C, 'H-1!! COSY and HMQC experiments (Table 
14).
Table 14 The !H and 13C NMR assignments of mellein.
No 8c 6«
1 1 7 0 0 -C
3 76.15 -C H 4.74 (m)
4 34.62 -  CH2 2.96 (d,^=7.13Hz)
5 117.95 -  CH 6.91 (d,J= 8.51 Hz)
6 136.19-CH 7.44 (dd, J= 8.42, 7.39 Hz)
7 116.23-CH 6.72 (d, J= 7.39)
8 162.17-C
9 108.29- C
10 139.43- C
11 20.80 -  CH3 1.54 (d ,J  6.20 Hz)
* Chelated OH 11.05 (s, OH)
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The first isolation of this compound was reported in 1933 from Aspergillus melleus 
7'8. It has also been isolated in Bradford from different Xylaria fungi, such as X. 
Longiarta 9, X. grammica 10 and X. badia u . In this project mellein has been found to 
be produced by several xylaria fungi species, which means that mellein is a common 
secondary metabolite from xylaria fungi. The yield of mellein from most of the fungi 
is very low compared to other metabolites. It has also been found that fungi which 
produce this metabolite can produce other derivatives such as 4-hydroxymellein and 
8-O-methylmellein.
Dimitriadis et al reported 12 the stereospecific synthesis to both enantiomers of 
mellein, where the optical rotation of the (S)-(+)-mellein is [a] 2D5 +88.6 (c 0.27,
MeOH) and for (R)-(-)-mellein is [a] 2DS - 101.3 (c .07, CHC13) (Figure 61). Islam et 
al reported the synthesis of (R)-(-)-mellein with the optical rotation as [a] ^  -102 (c 
0.53, CHCI3) 13. By comparing the above optical rotation with that of the isolated 
mellein, the latter was confirmed as (S)-(+)-mellein.
S-Mellein R-Mellein
Figure 61 S and R enantiomers of mellein
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4.3 Isolation of c/s-4-HydroxymeIlein from fungus A217R
The next UV active band in the PTLC at Rf 0.64, which also developed a strong 
orange colour when sprayed with diazotised p-nitroaniline spraying reagent; 
suggesting a phenolic compound, was recovered. The recovered silica was washed 
with ethyl acetate to give a yellow solution. The ethyl acetate was removed under 
low pressure to produce yellowish needles (255 mg), which were recrystallized from 
toluene to give white needles, 119 mg; mp. 117-120 °C; m/z 195 (M4); [a] 2„3 + 38 (c
0.5, MeOH); IR: vmax cm'13427, 3178, 2997,1675. IR absorptions at 3427 and 3178 
cm' 1 in the spectrum of this compound indicated the presence of two hydroxyl 
groups. The latter suggested a hydrogen bonded hydroxyl group, whilst the 
absorption at 3427 cm' 1 indicated a non-hydrogen bonded OH.
In the 'H NMR in CDCI3 (Figure 66) ten protons were indicated at §h 1.58 (3H, d, J
6.6 Hz), 2.18 (s (br)), 4.55 (1H, d, J  2.1 Hz), 4.68 (1 H, qd, J  2.1 Hz, J  6.62 Hz), 
6.91 (1H, d, J  7.30 Hz), 7.51 (1H, dd,J8.51 and 7.30 Hz), 7.01 (1H, dd, J8.51 Hz), 
10.97 (lH ,s).
The ,3C NMR (CDCI3, Figure 67) revealed ten carbons, which comprise a methyl 
carbon at 8c 16.15, five methine at 67.37, 78.33, 118.44, 118.67, and 136.94, and 
four quaternaries at 106.93,140.60,162.20, and 169.33.
From the mass spectrum, H and C NMR, the molecular formula was deduced to 
be C10H10O4, where there were two hydroxyl groups, one of which occurs at SH 2.18 
and another at 8h 10.97. The latter indicates a chelated hydroxyl group. Because of 
the yellow spot of this compound with diazotised p-nitroaniline, a hydroxyl group on 
the aromatic ring was likely. This information together suggested a mellein type 
compound. By comparing m/z of mellein to that of this compound, it is 16 unit larger
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than that of mellein, indicating an additional oxygen. The absence of a methylene 
signal in the carbon spectrum of this compound compared to that of mellein indicates 
this compound is substituted at C-4. The replacement of the methylene carbon in 
mellein with a down field methine carbon at 5C 78.33 suggested the substitution at 
C-4 to be a hydroxyl group, which means that this compound is 4-hydroxymellein. 
Comparison of the H and C NMR data of this compound with literature data 
showed it to be m -4-hydroxymellien 14'16 (Figure 64).
Figure 64 cis-4-hydroxymellien
The cis or trans configuration of the protons at C-3 and C-4 in 4-hydroxymellein is 
based on the coupling constant between the two protons. A coupling constant of 2 
Hz is consistent with the cis form, whereas a 4 Hz coupling constant is associated 
with the trans form.
The 3-H, 4-H coupling constant was observed to be 2.10 Hz. On this basis, the cis- 
configuration was assigned. A spin decoupling NMR experiment was performed by 
irradiation of the methyl group protons at position C -ll. This eliminated the 
coupling between the methyl group protons and the proton at position C-3. The 
quartet of doublet signal at 4.68 Hz was “collapsed” leaving a doublet peak. The J- 
coupling between the 3-H and 4-H measured at J= 2.08 Hz confirmed the coupling 
behaviour detected in the 'H NMR spectrum.
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The NMR data of the compound were established unambiguously using ID and 2D 
NMR spectral experiments, 'H, 13C, COSY-45 and HMQC experiments. HMQC 
revealed all H-C direct correlations and thus confirmed the assignment of all carbons 
with attached protons (Table 15).
Table 15 The *H and ,3C NMR assignments for 4-Hydroxymellein.
No 6c 5h
1 169.33-C —
3 67.37 -CH 4.68 (qd, 76.62,2.10)
4 78.33-CH 4.55 (d, 7 2.10 Hz)
5 118.67-CH 6.91 (d, 77.30)
6 136.94-CH 7.51 (dd, 78.51, 7.30)
7 118.44-CH 7.01 (d, 78.51)
8 162.20-C-OH 10.97 (s, -OH)
9 106.93 —
10 140.60 —
11 16.15-CH 3 1.58 (d, 76.6)
Because of two chiral centers in the molecule, four enantiomers are possible (Figure 
65).
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(3S,4S)-4-hydroxcymelein (A) (3R,4R)-4-hydroxcymelein (B)
(3S,4R)-4-hydroxcymelein (C) (3R,4S)-4-hydroxcymelein (D)
Figure 65 4-hydroxymellein enantiomers
4-Hydroxymellein of undetermined stereochemistry has been isolated from 
Aspergillus oniki17, Anisospora camptospora18, and Aspergillus ochraceus19. 
cis-3S,4S’-4-hydroxymellein (A) in addition to mellein have been isolated from the 
mycelium of Cercospora taiwanensis, grown on potato-agar. 20. 
3R,4R-4-Hydroxymellein (B) was found in Lasiodiplodia theobromae 1S, Septoria 
nodorum 21, Aspergillus melleus 22'23, Botryosphaeria obtuse 24 and from the 
mycelium of the coprophilous fungus Apiospwa monkzgnei25 
It also has been isolated from Papulaspora immersa, which was found in roots and 
leaves of Smallanthus sonchifolius. It showed strong synergistic cytotoxic activity 
with (22E,24R)-8,14-epoxyergosta-4,22-diene-3,6-dione against the human tumor 
cell lines MDA-MB435 (melanoma), HCT-8 (colon), SF295 (glioblastoma), and 
HL-60 (promyelocytic leukemia) 26,
3S,4R-4-Hydroxymellein (C) was isolated in Bradford University from the fungus 
Xylaria grammica 21. 3R,4S-4-Hydroxymellein (D) has been isolated from the
1 2 1
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medicinal plant Moringa oleifera 28 and together with the 3R,4R isomer from the 
fungus Septoria 29.
This isomer was also isolated from the marinederived fungus Cladosporium s p 30. 
Table 16 summarizes the optical rotation of each enantiomer. This identifies the 
isolated compound in this report as 3S,4S-4-Hydroxymellein. This the second report 
of this isomer.
Table 16 4-Hydroxymellein reported in the literatures
Enantiomer mp(°C) M d C) Source
3S, 4S (A) 118-119 +37.4° (c 0.33, MeOH at 20 °C) Cercospora
■ . 90taiwanensis
117-120 +38° (c 0.5, MeOH at 23 °C)
This case
3R, 4R(B) 114-115 -41 ±3° (CHCI3 at 20 °C) Septoria nodorum
21
112-117
Lasiodiplodia 
theobromae 18
133.5-135 -27.5° (c 0.04, CHCI3 at 23 °C) Aspergillus melleus
22-23
113-114 -39.6° (c 0.59, MeOH at 20 °C)
Microsphaeropsis 
strain31
3S, 4R(C) 135 +17.87° (c 0.71, CHCI3 at 23 °C) xylaria grammica
27
+7.08° (c 0.53, MeOH at 23 °C)
3R, 4S (D) 131-132 -28 (c 0.5, MeOH at 23 °C ) Cladosporium sp 30
-13° (c 0.53, CHCI3 at 20 °C ) Microsphaeropsis 
strain31
1 2 2
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C/s-4-hydroxymellein was tested for bioactivity 32'33. It showed good activity against 
the alga Chlorella fusca, and against the Gram positive Bacillus megaterium. It also 
showed antifungal activity against Microbotryum violaceumm, which suggests that 
the endophytic fungus could protect the host by producing metabolites, which may 
be toxic or even lethal to phytopathogens and highlights the potential of endophytic 
fungi in producing bioactive metabolites 32'33.
(3J?,4/?)-4-hydroxymellein and (3i?,45)-4-hydroxymellein were both isolated from 
Sphaeropsis sapinea 24. They showed a synergistic activity, when assayed for 
phytotoxic and antifungal activities on host and non-host plants 34.
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Figure 66 !H NMR spectrum of cis-4-Hydroxymellein
K)4*.
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4.4 Secondary metabolites from fungus A517R
The same procedures described for the isolation of secondary metabolites of A217R 
were applied to the ethyl acetate crude extract of the fungus A517R. It was found 
that this fungus produced exactly the same secondary metabolites as A217R, which 
means that the two fungi were the same species.
The mycelia of A217R and A517R did not show any significant quantities of 
secondary metabolites.
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C h a p te r  5 S econdary  m etabo lites from  fungus X.X04
5.0 Overview of Xylaria species X04:
Fungus X04 was collected from Thailand and classified as a Xylaria species (Xylaria 
cf. juruensis). The mycological data provided is summarised in Table 17. Figure 68 
shows 3 microscopic photos of X04.
Table 17 Description of X04
Host Dicot
Location Trad Province, Thailand
Stromatal size (cm) 1.7-3.0 cm long x 0.2-0.3 cm in diameter
Stromata! shape Cylindrical, with brown peeling layer, an acute 
sterile apex, roughened with perithecial contours, 
stipe with short hair
Texture Woody
Surface colour (outer) Brownish black
Surface colour (inner) White
Perithecial shape Spherical to obovoid
Ascospore colour Brown to darkbrown
Ascospore shape Inequilateral narrowly to broadly rounded ends
Ascospore size 9.0-12.0x3.0-4.5 urn
Figure 68 Microscopic images of X04
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The fungus was cultured for eight weeks on aqueous malt extract solution (3%) (16 
L) with added glucose (6%) in 32 x 1 L Thompson bottles. The fungus produced a 
white mycelium with gelatinous body and cylindrical shaped stromata with a black 
base as seen in Figure 69
The contents were filtered through a muslin cloth. The mycelium was left to air dry. 
The aqueous culture medium was extracted in batches with ethyl acetate (3*700 ml) 
using a 5 L separating funnel. The combined extracts were dried over anhydrous 
sodium sulphate. Removal of ethyl acetate under reduced pressure using a rotary 
evaporator gave a dark brown oily gum (8.5 g). The content of the viscous gum was 
examined by TLC using a number of different solvent systems.
The resultant plates showed that the solvent systems:- toluene : ethyl acetate : acetic 
acid (50 : 49 : 1), chloroform : methanol (95 : 5) and petroleum ether (60-80 °C) : 
ethyl acetate : acetic acid (50 : 50 : I) gave relatively similar separation patterns. 
The latter system was chosen.
5.1 Isolation and structu re  elucidation of coriloxin
Dark brown crystals were observed inside the gum from the ethyl acetate extract. 
The gum was triturated with toluene and gave needle-like crystals, which were
Figure 69 X04 fungus growing in a conical flask
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isolated and recrystallised twice from toluene to give colourless needles (2.5 g), mp 
153-155 °C; ES [M+H]+ m/z 171; [a]23D -98° (c 0.5 in MeOH); IRkb: v ^ c m ' 1 3398, 
2942,1650,1606.
The ' i f  NMR (CDCI3) spectrum (Figure 74) showed ten protons at 8h 5.26 (d, J2.02 
Hz, 1H), 4.49 (d J4.55 Hz, 1H), 3.77 (s, 3H), 3.34 (d .72.02 Hz, 1H), 2.59 (d, J4.55 
Hz, 1H) and 1.66 (s, 3H). The signal at 8h 5.26 is indicative of an olefinic methine 
proton, whilst the signal at 8h 4.49 indicates a methine proton adjacent to oxygen. 
The singlet signal at 8h 3.77 suggested a methoxy group.
The 13C NMR (CDCI3) spectrum (Figure 75) revealed eight carbon signals 
comprising two methyl signals at 8c 18.93 and 56.58, three methine signals at 8c 
60.57, 69.12 and 98.20 and three quaternary signals at 8c 59.44, 171.41 and 193.41. 
The NMR data together with the ES [M+H]+ m/z 173 suggested the presence of 4 
oxygen atoms to give a possible molecular formula of CgHi0O4.
The signal at 8c 193.41 can be assigned to a conjugated carbonyl group, which is 
supported by an IR absorption at 1650 cm'1. The 13C NMR signals at 8c 56.58, 
59.44, 60.57, and 69.12 suggested carbons adjacent to oxygen atoms. Excluding the 
carbonyl signal at 8C 193.41, 3 oxygen atoms are left for 4 carbons, which suggests 
the presence of epoxide group.
The spectral and physical data of this compound was compared with literature data 
and identified this compound as coriloxin (Figure 70). The ]H, 13C, DEPT-135 and 
HMQC NMR data are listed in Table 18.
131
Chapter 5
O
CH
7
3
Figure 70 Coriloxin
Table 18 *H and ,3C NMR data of Coriloxin
No Sc Multiplicity 5h
1 193.41 C
2 98.20 CH 5.26 (1H, d, 2.02 Hz)
3 171.41 C
4 69.12 CH 4.49 (1H, d, 4.55 Hz)
5 59.44 C
6 60.57 CH 3.34 (1H, d, 2.02 Hz)
7 56.58 c h 3 3.77 (3H, s)
8 18.93 c h 3 1.66 (3H, s)
9 OH OH 2.69 (d, 4.55 Hz)
Coriloxin was first isolated from Coriolus Vernicipes fungi in Japan It was also 
reported from unpolished rice fermented with a xylariaceous endophytic fungus 2. 
The antimicrobial activity of Coriloxin was investigated against Staphylococcus 
aureus, Pseudomonas aerugionsa and Candida albicans with MIC values of 100 pg 
/ml, 100 pg /ml and 200 pg /ml respectively. Coriloxin was also found to inhibit root 
growth of lettuce to 46% at a concentration of 50 pg/ml2.
Coriloxin has been isolated previously at Bradford University from X. Obovata 3 and 
X. Badia 4. Adeboya \  who reported the investigation of the absolute
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stereochemistry of coriloxin at the epoxy group(C5-C6) and C4 using Cotton curves, 
suggested the structure shown in Figure 71.
Figure 71 Coriloxin structure by Adeboya
Yoshihito et al 2 in 2005 also reported the investigation of the absolute 
stereochemistry of coriloxin at the epoxy group (C5-C6) and C4 using the same 
method and suggested the structure shown in Figure 72.
Figure 72 Coriloxin structure by Yoshihito e t  a l .
In order to resolve this confusion, X-Ray crystallography (Figure 73) has been used 
during the current investigation to determine the stereochemistry of coriloxin. The 
XRD data confirms that the correct configuration is that proposed by Yoshihito et al.
Figure 73 X-Ray crystallography of coriloxin
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Figure 76 DEPT-135 NMR spectrum of coriloxin
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5.2 Isolation of mellein from X04
The ethyl acetate extract (4.3 g), which remained after removal of coriloxin, was 
chromatographed over a silica gel column (60 x 2.5 cm). The column was eluted 
with a mixed solvent system [petroleum ether (60-80 °C), ethyl acetate and acetic 
acid (50:50:1)] and fractions of 3.0 ml were collected using an automated fraction 
collector.
The first component recovered (tubes 74-83) was yellowish oil, which was treated 
with «-hexane to give a white solid (8 mg), which was recrystallised from the same 
solvent to give white plates (3 mg) , mp 52-55 °C; ES [M+H]+ m/z 179; [a]2D3 -117° (c
0.05, MeOH). In the TLC plate eluted with petroleum ether (60-80 °C), ethyl acetate 
and acetic acid (50:50:1) or toluene, ethyl acetate and acetic acid (50:49:1) this 
compound had a Rf value of 0.92. It also showed a strong orange spot with p- 
nitroaniline spray reagent, but was not active with anisaldehyde spray reagent.
The 'H NMR spectrum (CDCI3) shows ten protons with signals at 5H 1.51 (3H, d, J  
6.42 Hz), 2.91 (2H, d, J 6.88 Hz), 4.71 (1H, m), 6.67 (1H, d, J7.34 Hz), 6.87 (1H, d, 
.78.25 Hz), 7.39 (1H, dd, J  7.39 and 8.42 Hz), 11.01 (1H, s). The 3 sets of signals in 
the aromatic region indicated a tri-substituted ring. The signal at 8h 11.01 suggests a 
chelated hydroxyl group. The signals at 5h 1.51, 4.71 and 2.91 represent a 
CH3CHCH2 subunit.
In the 13C NMR spectrum run in CDCI3 ten carbon signals comprise a methyl at 5c 
20.88, a methylene at 34.70, four methine carbons at 76.24, 116.32, 118.04, and 
136.27, and four quaternaries at 108.38, 139.52, 162.27, and 170.09. The mass 
spectrum, ]H and l3C NMR data, suggested a molecular formula of C10H10O3.
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Comparison of the spectral data, mp and the optical rotation of this compound with 
reported data identified this compound as R-mellein (Figure 77) 5'8
oh o
Figure 77 R-Mellein structure
'H, 13C and HMQC NMR data of mellein is given in Table 19. The structure 
elucidation of mellein is described in more detail in chapter 4.
Table 19 *H and ,3C NMR data (CDC13) of R-mellein
No 8c 8h
1 170.09- C
3 76.24 -C H 4.71 (1H, m)
4 34.70-C H 2 2.91 (2H, d, J 6.88)
5 118.04-C H 6.85 (1H, d, J8.25)
6 136.27-C H 7.39 (1H, dd, J7.33, 8.40)
7 116.32-C H 6.67 (1H, d, J7.34)
8 162.27- C
9 108.38-C
10 139.52- C
11 20.88-C H 3 1.51 (3H, d, y 6.20 Hz)
* Chelated OH 11.01 (1H, s)
The first isolation of this compound was in 1933 from Aspergillus melleus 6‘7. It has 
also been isolated at Bradford from different Xylaria fungi such as X.Longiana 8, 
X.grammica 9 and X.Badia 4. In this project S-mellein has been found to be 
produced by the xylaria fungi A217R and A517R described in chapter 4. which
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means that this metabolite is a common secondary metabolite for xylaria fungi. The 
yield of mellein from most of the fungi is very low compared to other metabolites. It 
has also been found that fungi, which produce this metabolite, can produce other 
derivatives such as 4-hydroxymellein and 8-methoxymellein.
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Figure 78 JH NMR spectrum of mellein from X04
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5.3 Isolation of stereoisomeric mixture of 4-Hydroxymellein
The second component collected from the column (tubes 85-100) had an Rf value of 
0.83 and gave orange spot with /»-nitroaniline spray reagent. It was isolated as white
m/z 195 [M + H]+ in its ES mass spectrum.
The 'H and 13C NMR spectra (Figure 81 and Figure 82) suggested a mellein 
derivative, which exists as a mixture of two isomeric forms in unequal ratio. The C-4 
methylene signals of mellein are absent and have been replaced by an oxygenated 
methine signal at 8h 4.56/4.58 and 5c 69.91/67.29. Replacement of the methylene 
group with a hydroxy-methine group at position 4 in mellein molecule gives 4- 
hydroxymellein (C10H10O4).
Comparison of the spectral data for this compound with reported data for 4- 
hydroxymellein (Table 20) confirms this compound as 4-hydroxymellein (Figure 80)
solid and recrystallised from hot petroleum as fine white needles, mp 119-122 °C;
OH OH
12
CH3
6 ^  ' v i i o ' '  ^ 3 ^ 1 1
5.
OH O OH O
13
Figure 80 4-Hydroxy mellein
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Table 20 NMR data for 4-Hydroxymellein in CDC13
Experimental results From X. Longiana 10
NO 6c DEPT 6H(mult) 6C 6H(mult)
1 168.59 C 169.24
1 169.29 C 169.32
3 78.30 CH 4.68 qd 78.30 4.61 qd
3 80.06 CH 4.60 m 80.02 4.70 q
4 67.29 CH 4.56 m 67.19 4.61 d
4 69.19 CH 4.58 m 69.06 4.70 d
5 118.39 CH 6.91 d 118.38 6.95 d
5 118.60 CH 7.00 m 118.48 7.01 dd
6 136.89 CH 7.51 qd 136.83 7.53 qd
6 136.97 CH 7.52 qd 136.90 7.55 qd
7 116.35 CH 7.01m 116.36 7.01 dd
7 117.87 CH 6.97 m 117.75 6.95 d
8 162.05 C 161.94
8 162.14 C 162.02
9 106.73 C 106.66
9 106.91 C 106.85
10 140.58 C 140.54
10 141.27 C 141.27
11 16.09 ch3 1.56(d) 16.02 1.52 (d)
11 18.00 ch3 1.50 (d) 17.94 1.60 (d)
* O-H 10.98 (s) 10.99 (s)
* 10.95 (s) 11.01 (s)
The 'H NMR spectrum (CDCI3) of the isomeric mixture of cis- and trans-A- 
hydroxymellein exhibited 6 down-field signals at 8H 6.91, 6.97, 7.00, 7.01, 7.51 and
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7.52 and six up-field signals at 5h 1.50, 1.56, 4.56, 4.58, 4.60 and 4.68 as well as 
two highly deshielded singlet at 5h 10.98 and 10.95).
The c/s-isomer was characterized by the presence of three downfield signals for 
aromatic protons in the 'H NMR, which appeared as one-proton doublets at 6.91 (J 
= 7.0 Hz) and 7.01 (J=  7.0 Hz), a one-proton triplet at 7.51 (J = 7.0 Hz), a three- 
proton at 5h 1.56 (d, J  = 6.5 Hz) for a methyl group, a one-proton doublet of a 
quartet at 8h 4.68 (J  = 2.06, 6.7 Hz) as well as a one-proton broad singlet at 2.5. 
Furthermore, a hydrogen-bonded phenolic proton appeared as a highly deshielded 
one-proton singlet at 10.98. The c/s-configuration was assigned to H-3 and H-4 on 
the basis of the small coupling constant (2.04 Hz) whereas the analogous trans­
isomer had a higher value 4.5 Hz n . This compound was isolated before in Bradford 
from X. longiana 10 and X. Grammica 9. However the metabolite profile of this 
fungus is different from above species.
Cw-4-hydroxymellein was previously isolated from several fungi, including 
Lasiodiplodia theobromae u , Cercospora taiwanensis 12, Aspergillus ochraceus 13 
and Aspergillus melleus 14 while the trans isomer was reported from Apiospora 
camptospora u , Septoria nodorum 15. In this project, the pure c/s-3S,4S-4- 
hydroxymellien was isolated from the fungus A217R and A517R described in 
chapter 4.
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Figure 81 !H NMR spectrum of 4-HydroxymelIein
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5.4 2-Hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione
The third component from the column chromatography (Tubes 110-135) was a 
mixture of two compounds. The main component gave a violet colour on the silica 
gel TLC plate at Rf 0.45 after a few hours exposure to air and light. Three 20 * 20 
cm silica gel PLC plates were used to separate 300 mg of the mixture. The violet 
band was recovered and washed with ethyl acetate to give orange crystals after the 
evaporation of the solvent. Recrystallisation from petroleum ether (80-100 °C) gave 
orange crystals (8.7 mg), mp 117-122 C, ES [M+H]+ m/z 183. The IR^ kbo spectrum 
showed the an absorption at 3348 cm'1, suggesting an OH group, 1640 cm'1 a 
conjugated carbonyl group and 1598 cm' 1 ’which may be due to a conjugated double 
bond.
A 'H NMR spectrum determined in CDCI3 (Figure 86) revealed 2 methyl signals at 
§H 1.49 (3H, t) and 1.93 (3H, s) methylene protons at SH 4.03 (2H, q), a singlet 
proton at 8h 7.28 (1H, s) and a methine proton at 8H 5.79 (1H, s), which could be an 
olefinic proton.
13C NMR spectrum in CDCI3 (Figure 87) and DEPT-135 NMR spectrum (Figure 
88) revealed 9 signals comprising two methyl groups at 8C 7.98 and 13.92, one 
methylene carbon signal at 65.96, a methine carbon at 8c 102.51 and five quaternary 
carbons at 8c 114.88, 151.61,160.57, 182.22 and 182.85. The last two carbon signals 
suggested conjugated ketone carbonyl groups.
The m/z 183 [M+H]+ combined with the NMR spectral data indicated a molecular 
formula C9 H 10O4  with 2 carbonyl groups conjugated with double bonds. This 
formula requires 5 degrees of unsaturation, which could be due to 2 carbonyl groups, 
2 double bonds and a ring; such as substructure A.
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The downfield methylene signal at 8C 65.96, which correlates to 8h 4.03 (q) in the 
HMQC NMR spectrum (Figure 89), indicated it is adjacent to an oxygen atom. The 
proton multiplicity suggested it was adjacent to a methyl group, which must be the 
one at 8h 1.49 (3H, t), which showed a cross peak with 5C 13.92. Adding the above 
information to substructure A gives substructure B.
o
The 'H-'H COSY spectrum wasn’t helpful in the assignment of the connectivity of 
the rest of the molecule. HMBC correlations were used to establish the structure. In 
the HMBC NMR spectrum (Figure 90), the methylene protons at 5H 4.02 showed a 
cross peak with 8c 160.57 which in turn showed a cross peak with the vinylic proton 
at 8 h  5.79, which correlates to the carbon at 8c 102.51 in the HMQC NMR spectrum.
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The vinylic proton also showed 2 more HMBC cross peaks with 5c 182.22 and 
151.61 to give substructure C.
The 8c 151.61 showed more HMBC correlations with the protons at 8H 1.93, which 
has a correlation with 5C 7.98 in the IIMQC NMR spectrum, and SH 7.25, which 
didn't show any correlation in the HMQC NMR spectrum (Figure 89) and it was 
considered as a hydroxyl proton. By adding the last described connectivity to 
substructure C, the final structure was confirmed (Figure 83 and Figure 84).
o
1.49 o
Figure 83 2-Hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione
ACD/LABS NMR prediction software (v.10) was used to assist the identification of 
the compound. The 'll and 1 ’C NMR predictors were used to predict the spectra for
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the suggested structure of the compound. The calculated values of the chemical 
shifts were compared with the experimental values as shown in Table 21 and showed 
good agreement.
Table 21 Experimental and calculated and I3C NMR data for 2- 
hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione
Experimental results Calculated values
C# 5c DEPT ôh (mult) Ô C DEPT Ôh (mult)
1 182.85 C 184.33 C
2 151.61 C 154.66 C
3 114.88 C 119.20 C
4 182.22 C 182.52 C
5 160.57 C 160.39 C
6 102.51 CH 5.79 102.87 CH 5.89
7 7.98 CH3 1.93 8.65 CH3 1.93
8 65.96 c h 2 4.03 65.76 c h 2 4.08
9 13.92 c h 3 1.49 13.92 c h 3 1.42
* OH 7.25 OH 7.03
O
9
H3c
Figure 84 2-Hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione
A literature search revealed that this compound is novel. A closely related compound 
(2-hydroxy-5-methoxy-3-methylcyclohexa-2,5-diene-1,4-dione) has been isolated 
previously at Bradford from Xylaria badia 4 ( Figure 85.).
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Figure 85 2-hydroxy-5-methoxy-3-methylcycIohexa-2,5-diene-l,4-dione
Xylaria badia was found to produce meilein, coriloxin and a naphthol glucoside in 
addition to the above benzoquinone derivative. Comparison of the metabolite profile 
of X04 and Xylaria badia, suggests that they are closely related species.
Quinones have an important role in the biosynthesis of many important compounds 
such as vitamin E and coenzyme Q 16"17.
5.5 Anti-malarial test
Coriloxin, cytochalasin D, mellein and 4-hydroxymellein were tested as anti- 
plasmodium agent against Plasmodium falciparum strain Kl. The test was done in 
The Bradford School of Pharmacy, University of Bradford by Dr Colin W. Wright’s 
research group. Coriloxin gave IC50 = 2.22 pg/mL (mean of two experiments), whilst 
the other compounds showed no activity at the highest dose tested (50 pg/mL).
Gessler et a l}% suggested that very good antiplasmodial acitivity extract should 
displayed an IC5 0  less than 10 pg/ml. Moderate activety for IC50 from 10 to 50 
pg/ml and over 50 pg/ml the extract was considered to have low activity.
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According to criteria suggested by Deharo et a/.19, an extract can be considered as 
good activety when its IC50 is less than 5 pg/mL, moderately active when its IC50 is 
between 5 and 10 pg/mL and inactive when its IC50 is over 10 pg/mL.
Based on the last criteria, Coriloxin with IC50 = 2.22 pg/mL can be concluded as 
having a good antiplasmodial activity, whilst the other compounds showed no 
activity at the highest dose tested (50 pg/mL).
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^  Figure 8 6  *H NMR spectrum of 2-Hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione
C
hapter 5
4 *
* S *
190J 1000 170J IMA 1500 140A 1300 IMA 110A 100A 90A MA 70A COA 500 40A MA MA 10A
Figure 87 ,3C NMR spectrum for 2-Hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione
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Figure 89 HMQC spectrum for 2-Hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione
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Figure 90 HMBC spectrum for 2-Hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione
C
hapter 5
Chapter 5
References
1. L. Nissan Chem. Ind. CO., Japan KoaiTokkyo Koho,, 1980.
2. Y. Shiono, T. Murayama, K. Takahashi, K. Okada, S. Katohda and M. Ikeda, 
Biosci. Biotech. Bioch., 2005, 69,287-292.
3. M. O. Adeboya, PhD. Thesis, Univefsity of Bradford, 1995.
4. E. K. Oppong, PhD. Thesis, University of Bradford, 2008.
5. Y. K. M. Sasaki, K. Oshita, H. Takamatsu, and Y. Asao, J. Agr. Biol. Chem, 
1970,34,1296.
6. M. J. Garson, J. Staunton and P. G. Jones, J. Chem. Soc., Perkin Trans. 
7,1984, 1021-1026.
7. S. Sugasawa, The Chemistry o f  Natural Products: Special Lectures, 1964, 1.
8. R. L. Edwards, D. J. Maitland, C. L. Oliver, M. S. Pacey, L. Shields and A. J. 
S. Whalley, J. Chem. Soc., Perkin Trans. 1, 1999, 715-720.
9. P. Pittayakhajonwut, Ph.D. Thesis, University of Bradford, 2000.
10. C. Oliver, Ph.D. Thesis, University of Bradford, 1997.
11. D. Aldridge, S. Galt, D. Giles and W. Turner, J. Chem. Soc. C, 1971, 1623- 
1627.
12. L. Camarda, L. Merlini and G. Nasini, Phytochemistry, 1976,15, 537-539.
13. R. J. Cole, J. H. Moore, N. D. Davis, J. W. Kirksey and U. L. Diener, J.
Agrie. Food Chem., 1971,19, 909-911.
14. M. Garson, J. Staunton and P. Jones, J. Chem. Soc., Perkin Trans. 7,1984, 
1021-1026.
15. M. Devys, M. Barbier, J. F. Bousquet and A. KoIImann, Zeitschrift fiir 
Naturforschung. C. J. Biosci., 1992, 47, 779-781.
16. R. E. Olson, G. H. Dialameh and R. Bentley, The biosynthesis of coenzyme 
Q in the rat, 1961.
17. R. Meganathan, Vitam. Horm., 2001, 61,173-218.
18. M. C. Gessler, M. H. H. Nkunya, L. B. Mwasumbi, M. Heinrich and M. 
Tanner, Acta Tropica, 1994, 56, 65-77.
19. E. Deharo, G. Bourdy, C. Quenevo, V. Muñoz, G. Ruiz and M. Sauvain, J. 
Ethnopharmacol., 2001, 77, 91-98.
158
Chapter 6
Chapter 6 Secondary metabolites from fungus X.6RD8
6.1 8-O-MethylmelIien
The fungus 6RD8 was collected in Thailand. It was cultured on 3% aqueous malt 
extract mixed with 6% glucose solution for 8 weeks to yield a thin yellowish white 
mycelium and a brown medium. The ethyl acetate extract of the latter gave a light 
brown gum (1.7 g). TLC examination of this gum using the solvent system toluene: 
ethyl acetate: acetic acid (50:49:1) showed 3 main metabolites, which were detected 
as UV active compounds and as yellowish orange spots when sprayed with p- 
nitroaniline spray reagent.
Trituration of the gum with light petroleum (60-80 C) afforded white crystals, which 
were crystallised from the same solvent to give white cubic crystals. After several 
days the remaining gum began to solidify as needle-like crystals. The solidified 
crystals were recrystallized from light petroleum ether (60-80 °C) to afford similar 
cubic crystals, (65.5 mg), mp 84-87 °C; ES [M+H]+ m/z 193 (CnHi0O3); [a] 2D2 + 
210 (c 1.0, MeOH), IR<ATO)Vmax cm' 1 2918, 1709,1596.
The 'l l  NMR spectrum (CDC13, Figure 92) revealed a methyl group at 6H 1.45 (3H, 
d, J  6.42 Hz), a methoxy group at SH 3.92 (3H, s), a methylene signal at 8H 2.84 
(2H, m), methine proton at 5H 4.53 (1H, m), aromatic protons at 6H 6.76 (1H, d, J  
7.34 Hz), 6.89 (1H, d, J8.25 Hz) and 7.43 (1H, dd, J7.57, 8.43 Hz).
The 13C NMR spectrum (CDC13, Figure 93) and DEPT-135 (Figure 94) showed 11 
signals at 6C 20.79 (CH3), 36.19 (CH2), 56.27 (CH3), 74.22 (CH), 110.98 (CH), 
113.74 (C), 119.29 (CH), 134.55 (CH), 142.08 (C), 161.27 (C) and 162.86 (C).
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The 'H NMR spectrum (Figure 92) shows that this compound is very similar to 
mellein except for the absence of the chelated hydroxyl signal at 5c 11.05 and the 
presence of a methoxy signal at 5c 3.95 (Table 22). Replacement of the chelated 
hydroxyl group with a methoxy group suggests 8-O-methylmellein. The IR spectrum 
of this compound showed the carbonyl absorption at 1709 cm' 1 whilst that of mellein 
is appearing at 1662. This can be explained to the hydrogen bond effect in mellein. 
Comparison of the spectral and physical data of this compound with the reported 
data for 8-O-methylmellein confirmed the suggestion 1>2, that the metabolite is (S)- 
(+)-8-0 -methylmellein (Figure 91).
Table 22 NMR data (CDCI3) of 8-O-methylmellein and mellein
8-O-methylmellien Mellein
No Sc Sh 5c SH
1 162.86 170.09
3 74.22 4.53 76.24 4.74
4 36.19 2.84 34.70 2.94
5 110.98 6.89 118.04 6.90
6 134.55 7.43 136.27 7.41
7 119.29 6.76 116.32 6.70
8 161.27 162.27
9 113.75 108.38
10 142.08 139.52
11 20.79 1.45 20.88 1.54
12 56.27 3.92 Chelated OH 11.05
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Me
Figure 91 Structure of S-8 -O-methylmelIein
R-8-O-Methylmellein was isolated for the first time by Devys et al from septoria 
nodorum x. The total synthesis has also been reported 3‘5. Dimitriadis et al reported 
the optical rotation of the S-8-O-methylmellein and R-8-O-methylmellein as [a] ZD5 
+2610 and -  250° (c 0.5, CHCI3) respectively 4. Islam et al reported the optical 
rotation of R-8-O-methylmellein as [a] ^  - 252° (c 0.55, CHCI3) 6.
S-8-O-Methylmellein was isolated for the first time in University of Bradford from 
undefined xylaria speicies ([a] 2DS +238 0 (c 1.02, CHCI3)) in addition to 
cytochalasin Q, D, N and O 2. This the second report of the S-enantiomer from a 
natural source.
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Figure 92 *H NMR spectrum of S-8-O-methylmeIIein
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Figure 93 13C NMR spectrum of S-8-O-methylmellein
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Chapter 7 Experimental
7.1 Culturing of the Fungi
7.1.1 Culture Room
The fungi used as a source of the secondary metabolites were cultured in a special 
room under specific conditions. The culture room was equipped with following 
essentials:
- An autoclave for sterilizing culture media before inoculation.
- A Bunsen burner to sterilise glasses and tools such as spatulas used during 
the culturing process.
- A thermostatic heating system to keep the culture room at stable temperature 
suitable for fungi growing.
- A thermometer to monitor room temperature.
7.1.2 Glassware inside the culture room
- Thompson bottles (1 L) and (2 L) to grow fungi on large scale.
- Conical flasks (250 ml) to grow the fungi on a small scale.
- Sample tubes with a screw cap to save master cultures of the fungi on agar 
slopes.
7.1.3 Sterilization
Sterilisation is the process that is used to kill microorganisms such as fungi, bacteria 
and viruses on a surface, equipment and biological culture media. This process was 
achieved using a chemical detergent and heating under elevated temperature and 
pressure as follows:
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First of all, the conical flasks and Thompson bottles were cleaned with water 
and a biocleaner detergent (2.5 % solution of Microcleanse from Teknon) 
using a cleaning brush.
After preparation of the culture medium, a Priorclave was used to complete 
the sterilisation process of the flasks and Thompson bottles containing the 
culture medium. The Priorclave uses steam at 121 C for 30 min. The process 
is completely automated in this modern autoclave (Figure 95).
Figure 95 The Priorclave uses steam at 121 °C for 30 min
7.1.4 Master culture
Master fungi samples were kept in 20 ml glass screw-capped tubes. They were 
prepared as following:
A suspension mixture of 3% malt and 2% agar was mixed with heating.
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20 ml sample tubes with cap were filled to approximately half their volumes 
with the prepared suspension.
The tubes and contents were sterilised by the Priorclave.
- The tubes then reheated again to 100 C for 5 min and set in a slope mode so 
the culture medium solidifies sideway in the tubes.
- Finally the tubes were inoculated with the fungus samples and labelled with 
code and date.
For each fungus 4-6 master cultures were prepared. The master cultures are 
used to sub-culture the fungi into conical flasks, which can be used to reform 
the master cultures, if required.
7.1.5 Conical flasks sub-culturing:
Each fungus was sub-cultured in 250 ml conical flasks for 2-3 weeks before they 
transferred into Thompson bottles. These conical flasks provide sufficient material 
for larger scale culturing. They also give information about the growth pattern of the 
fungi. The content of each conical flask can be used to inoculate 7-10 Thompson 
bottles.
7.1.6 Thompson bottles
Thompson bottles were used to culture the fungi for large scale as following:
- A conical flask containing the fungus sample was held horizontally and the 
cotton wool stopper was removed. The neck of the conical flask was 
sterilised over a Bunsen burner flame.
- The mycelium of the fungi was crushed into small pieces using a sterilised 
spatula.
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A small sample of material from the conical flask was added to each 
Thompson bottle, which contained sterilised culture medium.
Each set of Thompson bottles was labelled with the fungus code and 
culturing date and kept on shelves designed for this purpose.
The fungi bottles were observed for 8 weeks and any contaminated bottle was 
discarded. The culture room was kept dark at 25-27 C. The culturing process can be 
repeated several times as required using the master culture. Figure 96 shows the 
steps in the culturing process.
Figure 96 Culturing process steps.
7.2 Extraction process
After eight weeks the growing fungi were combined and the mycelium was separated 
by filtration through a muslin cloth. The mycelium was air-dried for two weeks. The 
medium was extracted in batches of 2.5 L approx., using ethyl acetate (3 x 700 ml) 
in a 5 L separating funnel. Each time the separation funnel was shaken gently for a
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few min and then left to settle until two distinct layers formed. The upper layers 
(ethyl acetate extract) were dried over sodium sulphate for 30 min. The ethyl acetate 
was then removed under reduced pressure using a rotary evaporator. Finally the 
crude yield of the metabolites was determined.
7.3 Chromatography process
Merck Kieselgel GF254 silica gel was used for column chromatography, thick layer 
and thin layer chromatography plates.
Pharmacia Fine Sephadex LH-20 was used in column chromatography to separate 
secondary metabolites from 6RD12 fungus (chapter 3) and Merck Kieselgel TLC 
silica gel 60 RP-18 F 2 5 4S. Column size and solvent systems used in each case are 
specified in context.
7.4 Spray reagents
- Anisaldehyde spray reagent was prepared as follows :
Anisaldehyde (1.0 ml) and concentrated sulphuric acid (1.0 ml) were added
to glacial acetic acid (98.0 ml).
p-nitroaniline spray reagent was prepared as follows:
A few drops of 5% sodium nitrite solution (see below) were added to 10% p- 
nitroaniline solution (50.0 ml) until the yellow colour of the solution 
disappears. Then sufficient quantity of 10% aqueous sodium carbonate 
solution was added until the yellow colour of the solution appears again.
(The 10% solution of p-nitroaniline was prepared by dissolving 7.0 g of p- 
nitroaniline crystals in concentrated hydrochloric acid (90.0 ml) and then 
diluted to 1 L.
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7.5 Crystallisation
The solvent conditions used for crystallisation of each pure secondary 
metabolite, with single or a mixture of solvents, is specified in each instance.
7.6 Physical properties
- Melting points were measured using a Kofler hot-stage apparatus and are 
uncorrected.
- IR spectra were obtained using a Perkin-Elmer Spectrum 100 FT-IR 
Spectrometer.
- ESI Mass spectra were determined using a Micromass ZMD (Single Quad) or 
a Micromass Quattro Ultima (Triple Quad).
High resolution Mass Spectrometry analyses were carried out on a Thermo 
LTQ Orbitrap XL mass spectrometer.
- Optical rotations were measured using a Perkin Elmer 141 Polarimeter 
equipped with cell length 1.0 dm.
- 'H and 13C and 2D NMR spectra were obtained on a JEOL ECA 600 NMR 
spectrometer or a Bruker Avance-400 NMR spectrometer.
- Carbon atom types were determined by employing a combination of 13C 
NMR broad-band proton-decoupled spectra, and Distortionless Enhancement 
by Polarisation Transfer (DEPT) experiments.
- Precise assignments were established by employing a combination of ID and 
2D NMR experiments.
- 2D NMR spectra were processed by JEOL Delta and/or ACD/Labs software. 
'H-’H correlations by double quantum-filtered COSY.
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'H-i3C NMR correlations were determined by using HMQC, HMBC and 
H2BC pulse sequences.
7.7 Secondary metabolites from the fungus A311R
The fungus A311R was surface cultured on an aqueous solution of 3% malt extract 
with 6% added glucose. The fungus was firstly sub-cultured in 4 conical Basks (250 
ml) for 3 weeks. It grew like white cotton on the surface of the medium. It started 
fruiting after 10 days. The initially white mycelium later turned brittle and black on 
the underside and supported un-branched, light brown-tipped xylaria-type fruiting 
bodies (Figure 97).
After 3 weeks, the fungus was transferred into 10x2 L Thompson bottles, each 
containing about 1000 ml of medium solution. After 8 weeks the mycelium was 
separated by filtration through a muslin cloth and left to air dry for 2 weeks. The 
brownish llltrate (10 L) was extracted in batches of 2.5 L in a separating funnel (5 L) 
with ethyl acetate (3 x 700 ml). The combined extracts were dried over anhydrous 
sodium sulphate for 30 minutes. After the removal of the ethyl acetate by rotary 
evaporation, a light brownish gummy mixture was obtained (4.32 g).
Figure 97 A311R fungus in a conical flask after 3 weeks
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TLC examination of this crude extract using toluene, ethyl acetate and acetic acid ( 
50:49:1) as eluent showed a brown spot at Rf 0.1 (Rf 0.3 in ethyl acetate : acetic acid 
98:1) after spraying the plates withp-nitroaniline spray reagent.
7.7.1 Isolation of nonane-1,2,3-tricarboxylic acid (2.1) from A311R
The crude extract was dissolved in warm chloroform and set aside for 24 h. A light 
brownish solid (0.90 g) precipitated from the solution. The solid was recovered by 
filtration and crystallised from nitromethane to give nonane-1,2,3-tricarboxylic acid 
(2.1) as white yellowish glass-like crystals (375 mg), mp (117-120 °C); HR^bitrap) 
ESI [M-H]' m/z 259.1177, requires Ci2H2o06; [a]2D° - 186° (c 1.0, MeOH) ; IR<Atr)
vmax cm'1 : 3091,1717, 1659 and 1175; ]H NMR 8H(C5D5N) 0.70 (3H, t, J 6 .5  Hz, 
10-CH3), 1.10 ( 4H, m), 1.23 (2H, m), 1.47 (1H, m, 6a-H), 1.62 (1H, m, 6b-H), 
1.86 (1H, m, 5a-H), 2.14 (1H, m, 5b-H), 3.46 (1H, m, 2-H) , 3.23 (1H, dd J3 .6 , 
14.0, 2-H ), 3.50 (1H, m, 4-H) and 4.12 (1H, m, 3-H); 13C NMR, 8C (C5D5N) 14.04 
(IO-CH3), 22.69 (9-CH2), 28.32 (6-CH2), 29.12 (5-CH2), 29.49 (8-CH2), 31.77 (7- 
CH2), 33.94 (2-CH2), 44.34 (3-CH), 47.42 (4-CH), 175.50 (11-COOH), 176.53 (1- 
COOH) and 177.00 (12-COOH).
7.7.2 Preparation of trimethyl nonane-I,2,3-tricarboxylate (2.1A)
A solution of 2.1 (50 mg) in methanol (1 ml) was reacted with ethereal diazomethane 
solution (2 ml). The resultant solution was stirred at 0 °C for 15 minutes. Then the 
solvent was removed by rotary evaporation to yield a yellowish-brown oily material. 
The latter was triturated with warm petroleum ether (60-80 °C) to give trimethyl 
nonane-1,2,3-tricarboxylate (2.1 A) as a brown oil (23 mg); ES [M+H]+ m/z 303 
(C i5H260 6); IR<atr) vmax cm'1 : 1735, 1743 and 1240; ‘H NMR, 8H (C5D5N) 0.72
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J7 .0  Hz, 10-H), 1.08 ( 6H, m), 1.23 (2H, m), 1.49 (1H, m, 5a-H), 1.73 (1H, m, 5b- 
H), 2.77 (1H, dd, J  4.3, 12.5, 2-H), 2.92 (2H, m, 2a, 4-H), 3.43 (1H, m, 3-H), 3.52 
(3H, s, 11 -COOMe), 3.59 (3H, s, 12-COO Me), 3.61 (3H, s, 1-COOM?); 13C NMR, 
5C (C5D5N) 13.98 (IO-CH3), 22.59 (9-CH2), 27.46 (6-CH2), 29.10 (5-CH2), 31.56 
(8-CH2), 29.13 (7-CH2), 33.26 (2-CH2), 43.24 (3-CH), 46.52 (4-CH), 51.58 (14- 
OMe), 51.65 (15-OMe), 51.92 (13-OMe) ,172.28 (1I-Q , 174.25 (1-Q and 173.50 
(12-Q.
7.7.3 Preparation of ethereal alcoholic solutions of diazomethane 1-2:
Ethanol (25ml, 95%) was added to a solution of potassium hydroxide (5 g) in water 
(8 ml) in a (100 ml) distillation flask fitted with dropping funnel and an efficient 
condenser set downward for distillation. The condenser was connected to two 
receiving flasks in series, the second of which contained ether (25 ml). The inlet tube 
of the second receiver dipped below the surface of the ether, and both receivers were 
cooled to 0 °C. The flask containing the alkali solution was heated in a water bath to 
65 °C, and a solution of diazald (21.5 g, 0.1 mole) in about 200 ml of ether was 
added through the dropping funnel in about 25 minutes. The rate of distillation 
should be about equal the rate of addition. When the dropping funnel was empty, 
another 40 ml of ether was added slowly and the distillation was continued until the 
distilling ether was colourless .The combined ethereal distillate contained about 3 g 
of diazomethane.
Diazomethane is not only exceedingly toxic, but its solutions have been known to 
explode quite unexpectedly. Hence, all work with diazomethane, regardless of how it 
is generated, should be carried out behind safety shields in efficient hoods.
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7.7.4 Isolation of spiculisporic acid (2.2) from A311R
A brown spot was observed on a silica gel plate at Rf 0.3 developed using ethyl 
acetate : acetic acid (99:1) mobile phase, when sprayed with p-nitroaniline spray 
reagent. 1 g of the ethyl acetate crude extract was applied to preparative silica plates 
(5 x 20 cm x 20 cm) to isolate this compound. Ethyl acetate : acetic acid (99:1) was 
used as mobile phase to develop the plate. The band was then removed and washed 
with ethyl acetate to give light brown solid, which was crystallised from 
nitromethane to give colour less crystals of spiculisporic acid (28 mg); mp 142-145 
°C, (lit.3, mp 140-143 °C); HR<orbitrap) ESI [M -H ]' m/z 327.1809 (C i7H2806); [a]2D° -
12° (c 0.25, EtOH), (lit. 3 , [a] ™ -  15° ( EtOH); IR(ATR) Vmax cm'1 : 2952, 2551,1791,
1778 and 1710; ]H NMR, SH (C5D5N) 0.77 (3H, td, J  6.0, 2.3 Hz, 15-CH3), 1.07 ( 
8H, m), 1.14 (4H, m), 1.53 (1H, m, 7a-H), 1.68 (1H, m, 7b-H), 1.93 (1H, m, 6a-H), 
2.33 (1H, m, 6b-H), 2.70 (1H, m, 3b-H), 2.83 (3H, m, 2a, 2b and 3a-H), 3.66 (1H, 
dd J  10.77, 2.75, 5-H); 13C NMR, 8C (C5D5N) 14.14 (15-CH3), 22.76 (14-CH2), 
28.48 (7-CH2), 28.74 (6-CH2), 28.75 (2-CH2), 29.39 (8-CH2), 29.57 (12-CH2), 
29.68 (11-CH2), 29.69 (9,10-CH2), 30.12 (13-CH2), 31.92 (3-CH2), 52.14 (5-CH), 
87.63 (4-C), 174.52 (16-COOH), 175.12 (17-COOH) and 176.82 (1-C).
7.7.5 Preparation of Dimethyl ester of spiculisporic acid
A solution of spiculisporic acid (15 mg) in methanol (1 ml) was reacted with ethereal 
diazomethane solution (2 ml). The resultant solution was stirred at 0 °C for 15 
minutes. Then the solvent was evaporated to yield a yellowish-brown oily material. 
The latter was triturated with hot petroleum ether (60 -80 °C) to give dimethyl 
spiculisporate as a brown waxy material (7 mg); HR^itrap) ESI [M - CH3]' m/z 
341.1966 (C i9H320 6); IR<atr) vmax cm'1 : 2923, 1764 and 1740; ’l l  NMR, 5H
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0.78 (3H, td, J  6.0. 2.3 Hz, 15-H), 1.11 (1 1H, m), 1.18 (4H, in), 1.26 (1H, m, 7a- 
H), 1.34 (1H, m, 6b-H), 1.65 (1H, m, 6a-H), 2.56 (3H, m, 12a and 12b, 4-H), 2.67 
(1H, m, 3a-H), 3.26 (1H, dd, J 10.77, 2.75, 5-H), 3.67 (3H, s, 17-COOMe), 3.63 
(3H, s, 19-COOA/e); 13C NMR, 5c(C5DsN) 14.13 (15-CH3), 22.77 (14-CH2), 27.92 
(7-CH2), 27.95 (6-CH2), 27.99 (2-CH2), 29.37 (8-CH2), 29.40 (12-CH2), 29.43 (11- 
CH2), 29.56 (9-CH2), 29.64 (10 and 13-CH2), 31.94 (3-CH2), 52.88 (5-CH), 86.52 
(4-C), 51.85 (18-OMe), 51.88(19-0Me), 171.53(16-C), 1 72.54 (17-C) and 175.68
(1-C).
7.8 Secondary metabolites from the fungus 6RD12
The fungus 6RD12 was collected in Thailand and classified as a xylaria species. The 
front view of the Petri dish showed a white mycelium overlaid with some black 
concentric rings. The back view of the Petri dish of the fungus 6RD12 showed an 
orange underside to the mycelium (Figure 98).
Figure 98 Front and back view of 6RD12 in the Petri
dish
The fungus 6RD12 was firstly surface sub-cultured on an aqueous solution of 3% 
malt extract with 6% added glucose.in 4 conical flasks (250 ml) for 3 weeks. Initially 
a white cotton wool like mycelium formed on the medium surface. It started fruiting 
after 10 days. It developed black cylindrical stromata with white tips.
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The fungus was then cultured in Thompson bottles (8 x 2 L) for 8 weeks. The fungus 
during the first 4 weeks produced a white mycelium, which then developed black 
areas.
After 8 weeks the mycelium was separated by filtration through a muslin cloth and 
left to air dry for 2 weeks. The brownish filtrate (8 L) was extracted in batches of 2.5 
litres approx, with ethyl acetate (3 x 700 ml) using a separating funnel (5 L). The 
combined ethyl acetate extracts were dried over anhydrous sodium sulphate for 30 
minutes. After the removal of the ethyl acetate by a rotary evaporator, a light 
brownish gummy mixture was obtained (3.35 g).
7.8.1 Isolation and structure elucidation of 4,5,6-trihydroxy-3-propyl-3,4,6,7- 
tetrahyd ro-l/7-isoch romen-8(5//)-on e 3.1
A normal phase TLC of the ethyl acetate extract eluted with toluene, ethyl acetate 
and acetic acid (50:49:1) revealed little of interest other than a dark brown spot at the 
origin of the TLC plate. As a result, a reverse phase TLC plate was used with 
methanol : water (50:50) as eluent. The plate showed 3 UV active spots at Rf 0.96, 
0.85 and 0.46. A chromatography column (50 x 2.0 cm) was packed with Sephadex 
LH20 (70 g) in methanol-water (80:20). The crude extract (3 g) was adsorbed onto 
the top of the column, which was eluted with a methanol-water (80:20). Fractions of 
4 ml were collected. The first compound (3.1) collected from (tubes 24-26, 
methanol-water (80:20), was 4,5,6-trihydroxy-3-propyl-3,4,6,7-tetrahydro-l//- 
isochromen-8(5//)-one as a white solid (95 mg), mp 180-185 °C, HR^ orbitrap) ESI 
[M+H]+ mlz 243.12274, (C12H18O5); [a]2D2 - 160° (c 0.5, MeOH); lR(KBr) vmax cm'1:
3378, 1673, 1105 and 1402; 'HNMR (C5D5N) 0.82 (3H, t, J 1 A  Hz, 13-H), 1.43(m, 
12b-H), 1.62 (2H, m, llb-H  and 12a-H), 2.04 (1H, m, lla-H), 3.65 (1H, td, .72.75,
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8.1 Hz , 3-H), 4.75 (1H, m, 4-H), 5.42 (1H, bs, 5-H), 4.51 (1H, m, 6-H), 2.81 (1H, 
dd ,J3 .6 , 15.81 Hz 7a-H), 3.21 (1H, dd, J8 .1 , 15.81, 7b-H), 4.77 (1H, d, .715.81, 
la-H), 4.42 (1H, dt, J  2.4, 16.3, lb-H); 13C NMR, 5C (C5D5N), 14.17 (13-CH3), 
18.98 (12-CH2), 34.91 (II-CH2), 79.08 (3-CH), 66.82 (4-CH), 66.48 (5-CH), 66.59 
(6-CH), 43.50 (7-CH2), 63.76 (1-CH2), 132.6 (9-C), 155.27 (10-C), 197.08 (8-C).
7.8.2 Isolation and structure elucidation of cycloepoxydon 3.2 from fungus 
6RD12
The fractions (38-44, methanol-water 80:20) were collected and combined together 
according to the Rp TLC plate where they showed weak UV absorption at Rf 0.85. 
After the solvent was removed, the residual brownish white solid (17.4 mg) was 
recrystallised from nitromethane to give cycloepoxydon as colourless crystals (7.3 
mg ) , mp 186-189 °C, ES [M+H]+ m/z 241; [a]2D2 - 139° (c 0.25, CHCljiMeOH
(95:5), {lit. 4 [a]2D2 -145° [c 1.1, CHCl3:MeOH (95:5)]4; IR ^ o  vmax cm’1: 3378,
1676, and 1105 ; 'H NMR [(CD3)2CO], 6H 0.89 (3H, t, J7 .2  Hz, 13-H), 1.36 (1H, 
m, 12a-H), 1.38 (1H, m, 1 la-H), 1.41(1H, m, 12b-H), 1.79 (1H, m, 1 lb-H), 3.19 
(td, J2.6, 8.4, Hz , 3-H), 3.34 (1H, d, J4 .1  Hz, 7-H), 3.85 (1H, t, /3 .95 , 6-H), 4.12 
(1H, dd, 16.9, 1.9 Hz, laH), 4.15 (2H, m, lb-H and 4-H), 4.95 (1H, bs, 5-H); 13C 
NMR, 5C [(CD3)2CO], 13.52 (13-CH3), 18.49 (12-CH2), 34.4 (11-CH2), 78.27 (3- 
CH), 66.76 (4-CH), 63.63 (5-CH), 55.12 (6-CH), 53.21 (7-CH), 63.29 (1-CH2), 
128.49 (9-C), 151.79 (10-C), 192.73 (8-C).
7.9 Secondary metabolites from the fungi A217R and A517R
The Petri dishes front and back views of A217R and A517R looked similar. Both 
fungi were sub-cultured in conical flasks of aqueous 3% malt to prepare them for
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large scale culturing. After 3 weeks the conical flask content were transferred into 
Thomson bottles (6 x 2 L) containing aqueous 3% malt enriched with 6% glucose (1 
L) and left to grow for eight weeks. They formed a white gelatinous mycelium 
(Figure 99). The mycelium was removed by filtration through muslin cloth and the 
aqueous filtrate extracted in portions with ethyl acetate (3 x 700 ml) in a separating 
funnel (5 L). The combined extracts were dried over sodium sulphate for 30 min. and 
the ethyl acetate removed by a rotary evaporator to give a brownish gummy material 
(5.5 g of A217R and 6.2 g of A517R).
Figure 99 Fungus A517R in Thomson bottle after 8 weeks
The extracts were then analyzed for their content by hand made TLC plates made 
from Merck Kieselgel GF254 silica gel. A solvent system of toluene: ethyl acetate: 
acetic acid (50:49:1) was used to develop the plates. Both fungi showed similar TLC 
results. Under visible light, a violet coloured spot was observed at Rf. of 0.58. Under 
short wave UV (245 nm), three UV active spots were detected; a weaker spot at the 
lower Rf. of 0.27 and two stronger spots at 0.65 and 0.90.
TLC plate sprayed with p-nitroaniline developed a strong orange colour spots at Rf 
0.65 and 0.90 and an opaque spot at Rf. of 0.27.
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7.9.1 Isolation and structure elucidation of cytochalasin D from A217R
The ethyl acetate extract (5.5 g) was triturated with ethyl acetate and left overnight. 
A white precipitate was obtained. The white solid was filtered off and recrystallized 
from ethyl acetate to give cytochalasin D as white needle crystals (65 mg), mp 238- 
240 °C; ES [M+H]+ m/z 508 (consistent with C30H37NO6); IR(KBr) vmax cm'1: 3681, 
2919, 1739 and 1689; XH NMR (C5D5N) 5H 0.77 (3H, d, J  6.70 Hz, 11-H), 0.98 (3H, 
d, J  6.50 Hz, 22-H), 1.50 (3H, s, 23-H), 1.93 (1H, dd, J5 .0 , 11.8 Hz, H-15), 2.33 
(3H, s, 25-H), 2.42 (1H, m, 4-H), 2.66 (1H, m, 16-H), 2.86 (2H, m, 10-H), 2.97 (1H, 
m, 5-H) 3.38 (1H, t, J  10.5, 8-H), 3.55 (1H, m, 3-H), 4.39 (1H, d, J  10.1 Hz, 7-H), 
5.41 (3H, s, 12-H), 5.60 (1H, m, 13-H), 5.57 (1H, m, 19-H), 6.01 (1H, s, 21-H), 6.34 
(2H, m, 14-H), 6.84 (1H, dd, J2.23, 15.8 Hz, H-20), 7.14 (2H, m, Ar-H), 7.22 (2H, 
m, Ar-H), 7.24 (2H, m, Ar-H); 13C NMR(C5D5N) 5c 13.59 (11-CH3), 19.34 (22- 
CH3), 20.51 (25-CH3), 24.61 (23-CH3), 33.14 (5-CH), 38.54 (15-CH2), 42.43 (16- 
CH), 45.49 (10-CH2), 47.87 (8-CH), 50.07 (4-CH), 53.99 (9-C), 54.36 (3-CH), 
71.27 (7-CH), 77.99 (21CH), 78.39 (18-C), 112.17 (12 =CH2), 126.79 (13-CH), 
127.84 (29-Ar-CH), 128.79 (28, 30-ArCH), 129.90 (27, 31-ArCH), 132.95 (20-CH), 
132.80 (14-CH), 133.82 (19-CH), 138.44 (26-ArCH), 151.63 (6-C=), 170.47 (24- 
C=0), 175.11 (1-C=0) and 210.88 (17-C=0).
7.9.2 Isolation and structure elucidation of S-mellein from A217R
After the isolation of cytochalasin D, the ethyl acetate crude extract obtained from 
the fungus A217R (4.0 g) was treated with warm toluene to give a yellow oily 
material (1.1 g). Preparative TLC (8x, 20 * 20 cm) was run using toluene : ethyl 
acetate : acetic acid (50:49:1) solvent system to separate the content of the toluene 
fraction, which showed two main compounds at Rf 0.90 and 0.65. The UV
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fluorescent band at Rf. 0.90 was recovered and then washed with ethyl acetate to 
produce a clear yellow solution. The ethyl acetate was removed under low pressure 
to yield yellow oil (34 mg). The oil was triturated with «-hexane to produce yellow 
solid (7.5 mg), which was recrystallised from the same solvent to give S-mellein as 
white plates (4.0 mg), mp 53-55 °C; ES [M+H]+ m/z 179; [a] 2D3 + 85 (c 0.05,
MeOH), [lit5. mp 55-56 (ether/hexane), [a] 2D5 +88.6 (c 0.27, MeOH]; *H NMR: (600
MHz, CDC13) 5h 1.54 (d, J  6.27 Hz, 3 H, 9-H) 2.96 (d, J7.13 Hz, 2 H, 4-H) 4.74 (m, 
1 H, 3-H) 6.72 (d, J  7.39 Hz, 1 H, 5-H) 6.91 (d, J  8.51 Hz, 1 H, 7-H) 7.44 (dd, J  
8.42, 7.39 Hz, 1 H, 6-H) 11.01 (s, 1 H, 8-OH). 13C NMR (CDC13) 5C 20.80 (CH3, 
11-C), 34.62 (CH2, 4-C) 76.15 (CH, 3-C), 108.29 (C, 9-C), 116.23 (CH, 7-C), 
117.95 (CH, 5-C), 136.19 (CH, 6-C), 139.43 (C, 4-C), 162.17 (C-OH, 8-C), 170.00 
(C=0, 1-C).
7.9.3 Isolation and structure elucidation of c/s-4-Hydroxymellein from A217R
The next UV active band in the PTLC at Rf 0.64 was removed and then washed with 
ethyl acetate to produce a clear yellow solution. The ethyl acetate was removed 
under low pressure to produce yellowish needles (255 mg) which were recrystallized 
from toluene to give c/.v-4-hydroxymellein as white needles (119 mg), mp 117-120 
°C; ES [M+H]+ m/z 195, [a] 2D3 + 38° (c 0.5, MeOH), [lit.6, mp 118-119 °C, [a] 2D° +
37.4° (c 033, MeOH)]; IR<KBr) vmax cm' 1 3427, 3178, 2997, 1675; *H NMR: (600 
MHz, CDCI3) 5h 1.58 (3H, d, J 6.6 Hz, 9-H), 4.55 (1 H, d, J2 .10  Hz, 4-H) 4.68 (1 
H, qd, J2.10, 6.62 Hz, 3-H) 6.91 (1 H, d ,J7.30,H z, 5-H) 7.01 (1 H, d, J8.51 Hz, 7- 
H) 7.51 (1 H, dd, J8.51, 7.30 Hz, 6-H) 10.97 (1 H, s, 8-OH). 13C NMR: (CDC13) 8C 
16.15 (CH3, 11-C), 67.37 (CH, 3-C), 78.33 (CH-OH, 4-C), 106.93 (C 9-C), 118.44
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(CH, 7-C), 1 18.67 (CH. 5-C), 136.94 (CH, 6-C). 140.60 (C C-10), 162.20 (C, 8-C), 
169.33 (C=0, 1-C).
7.9.4 Secondary metabolites from A517R
The same procedures described for the isolation of secondary metabolites of A217R 
were applied to the ethyl acetate crude extract of the fungus A517R. It produced 
cytochalasin D (54 mg), mellein (5 mg) and c/.v-4-hydroxymellein (72 mg).
It was found that this fungus produced exactly the same secondary metabolites as 
A217R, which suggests that the two fungi are possibly the same species.
The mycelia of A217R and A517R did not show any interesting secondary 
metabolites.
7.10 Secondary metabolites from fungus X04
The fungus X04 was surface cultured on an aqueous solution of 3% malt enhanced 
with 6% glucose. The fungus was firstly sub-cultured in 5 conical flasks (250 ml) for 
2 weeks. It grew like white cotton on the medium surface. It was fruiting after 12 
days (Figure 100).
A) in a Petri dish B) in a conical flask after 2 weeks.
Figure 100 Fungus X04
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After 2 weeks, the fungus was transferred into 30 x 1 L Thompson bottles, each 
containing about 500 ml of medium solution. Figure 101 shows fungus X04 inside 
the Thompson bottle after 4 weeks.
After 8 weeks the mycelium was separated by filtration through a muslin cloth and 
left to air dry for 10 days. The brownish filtrate (15 L) was extracted in portions of 
2.5 L with ethyl acetate (700 ml) three times. The combined extracts were dried over 
anhydrous sodium sulphate for 30 minutes. After the recovery of ethyl acetate by a 
rotary evaporator, a light brownish gummy mixture was obtained (8.5 g).
Figure 101 Fungus X04 inside the Thompson bottle after 4 weeks.
TLC examination of this crude extract in different solvents system showed that this 
extract was a mixture of several minor compounds but only two major components.
7.10.1 Isolation of Coriloxin from fungus X04
The gummy mixture was triturated with hot toluene and left overnight. A yellow 
solid (4.31 g) was obtained, which was recrystallized 3 times from toluene to give 
coriloxin as colourless needle-like crystals (2.5 g), mp 153-155 °C (lit. 7 mp 153- 
155) ; ES [M+H]' m/z 171 (consistent with CgHioCXt); [a] 2D3 -98.4° (c 0.5, MeOH),
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[lit., 7 [a] ZD° -100° (c 033, EtOH]; IR<KBr) vmax cm' 1 3398, 2942, 1650, 1606; ]H NMR 
(CDC13) 8h 5.26 (1H, d, 2.02 Hz), 4.49 (1H, d, 4.55 Hz), 3.77 (3H, s), 3.34 (1H, d,
2.02 Hz), 2.69 (1H, d, 4.55 Hz) and 1.66 (3H, s); 13C NMR; 5C (CDCI3) 18.91 (8- 
CH3), 56.56 (7-CH3), 59.43 (5-C), 60.55 (6-CH), 69.10 (4-CH), 98.18 (2-CH), 
171.40 (3-C), 193.41 (1-C);
7.10.2 Isolation of S-mellein from fungus X04
The ethyl acetate extract of the medium of X04 (4.3 g) was chromatographed over a 
silica gel column (60 x 2.5 cm). The column was eluted with a mixture solvent 
system petroleum ether, ethyl acetate and acetic acid (50:50:1) and fractions of 3.0 
ml were collected using a fraction collector.
The first component recovered (tubes 74-83) was yellowish oiI( Rf 0.92), which was 
triturated with «-hexane to give a white solid (8 mg), which was recrystallised from 
the same solvent to give S-mellein as white plates (3 m g), mp 52-55 °C; ES [M+H]+ 
m/z 179; [a]2D3 -117° (c 0.05, MeOH), (lit. 8 [a] “  -100° (c 1.0, CHC13); lH NMR
(CDCI3) 5H 1.51 (3H, d, J 6.42 Hz), 2.91 (2H, d, J 6.88 Hz), 4.71 (1H, m), 6.67 (1H, 
d, .77.34 Hz), 6.87 (1H, d, J8.25 Hz), 7.39 (1H, dd, .77.39 and 8.42 Hz), 11.01 (1H, 
s); 13C (CDCI3) 6c 20.88 (H-CH3), 34.70 (4-CH2), 76.24 (3-CH), 116.32 (7-CH),
118.04 (5-CH), 136.27 (6-CH), 108.38 (9-C), 139.52 (10-C), 162.27 (8-C), and 
170.09 (1-C).
7.10.3 Isolation of cis,frarts-4-hydroxymellein mixture from fungus X04
The second component (tubes 38-52) collected from the column gave a white solid 
(12 mg), which was recrystallised from petroleum ether (60-80 °C) as fine white 
needles (4.3 mg) and found to be a mixture of two 4-hydroxymellein stereoisomers
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(C 10H 10O4 ); mp 117-122 °C; ES [M+H]+ m/z 195; 'HNMR, 5h (CDC13) 1.50 (3H, d, 
J  6.19 Hz, CH3), 1.56 (3H, d, J6 .59  Hz, CH3), 2.15 (1H, s(br), OH), 4.68 (1H, dq, 
J  2.06 and 6.70, Hz, 4-H), 4.60 (1H, m), 4.56 (1H, m), 4.58 (1H, m), 6.91(1H, d, J  
7.22 Hz, Ar-H), 6.97(1H, d, J  8.43 Hz, Ar -H), 7.00 (1H, dd, J  8.43 Hz, Ar -H), 
7.01 (1H, d, J7.70  Hz, Ar -H), 7.51 (1H, dd, J  8.43, 7.70 Hz, Ar -H), 10.99 (1H, s, 
chelated OH); 13C NMR, 5C (CDC13) 16.09, 18.00 (11-CH3); 67.29, 69.19 (3-CH); 
78.30, 80.06 (4-CH); 106.73, 106.91 (9-C); 116.35, 117.87 (7-CH); 118.39, 118.60 
(5-CH); 136.89, 136.97 (6-CH); 140.58, 141.27 (10-C); 162.05, 162.14 (8-C); 
168.59, 169.29 (1-C).
7.10.4 Isolation of 2-hydroxy-5-ethoxy-3-methylcyclohexa-2,5-dien-l,4-dione 
from fungus X04
The third component from the column chromatography was a mixture of two 
compounds (tubes 110-170). Three 20 x 20 cm PLC plates were used to separate 300 
mg of the mixture. The chromatogram was developed using toluene, ethyl acetate 
and acetic acid (50:49:1) as the solvent system. The violet band was removed and the 
compound was extracted from the silica by washing with ethyl acetate to give orange 
crystals after evaporation of the solvent. Recrystallisation from petroleum ether (bp 
80-100 °C) gave orange crystals of 2-hydroxy-5-ethoxy-3-methylcyclohexa-2,5- 
dien-l,4-dione (8.7 mg), mp 117-122 0 C. ES [M+H]+ m/z 183 (consistent with 
C9H10O4), IR(KBr) Vmax cm'1, 3348, 2925, 1640, 1598 and 1460; *H NMR (CDC13), 8H 
1.49 (3H, t, CH3), 1.93 (3H, s), 4.03 (2H, q, CH2), 5.79 (1H, s) and 7.28 (1H, s, OH); 
13C NMR (CDC13) 5c, 7.98 (CH3), 13.92 (CH3), 65.96 (CH20), 102.51 (CH), 114.88 
(C-3), 151.61 (C-2), 160.57, (C-5), 182.22 (C=0), 182.85 (C=0).
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7.11 Secondary metabolites from fungus 6RD8
The fungus 6RD8 (Figure 102) was collected from Thailand and classified as a 
xylaria species. It was cultured on an aqueous solution of a mixture of 3% malt 
extract and 6% glucose for 8 weeks. It yielded a thin yellowish white mycelium and 
4 L brown medium.
Figure 102 6RD8 fungus
7.11.1 Isolation of 8-0-methylmeIlein from fungus 6RD8
Ethyl acetate extraction of the culture medium gave light brown gum (1.7 g). 
Trituration of the gum with light petroleum ether (60-80 °C) afforded white cubic 
crystals, which were recrystallized from the same solvent to give S-8-0- 
methylmellein (65.5 mg), mp 84-87 °C (lit. 5. 86.5-87.5, ether/hexane); ES [M+H]+ 
m/z 193 (C,iHio0 3); [a] 2D2 + 210 0 (c 1.0, MeOH) [lit. 9 [a] 2D3 + 238 ° (c 1.02,
CHCh)]; IR(atr) Vmax cm'1 2918, 1709, 1596; 'H NMR (CDC13), 5„ 1.45 (3H, d, J
6.42 Hz, 11-CH3), 2.84 (2H, m, 4-CH2), 3.92 (3H, s, 12-CH30), 4.53 (1H, m, 3-H), 
6.76 (1H, d, .7 7.34 Hz, 7-H), 6.89 (1H, d. .7 8.25 Hz, 5-H), 7.43 (1H, dd, .7 7.57,
8.43 Hz, 6-H); l3C NMR, 5C (CDC13) 20.79 (11-CH3), 36.19 (4-CH2), 56.27 (12- 
CH3), 74.22 (3-CH), 110.98 (5-CH), 113.74 (9-C), 119.29 (7-CH), 134.55 (6-CH), 
142.08 (10-C), 161.27 (8-C) and 162.86 (1-C).
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Chapter 8 Summary
Endophytic fungi are an important source of novel compounds 1 and bioactive 
agents, which can lead to the development of new drugs for the pharmaceutical and 
agricultural industries 2.
In this study, secondary metabolites from six endophytic Xylaria fungi, collected 
from the Kao Loung National Park in Thailand, were investigated. The structures of 
the compounds were elucidated by chemical and spectroscopic methods.
The fungi were static surface cultured on an aqueous malt extract-glucose medium. 
The fungus A311R produced nonane-1,2,3-tricarboxylic acid (Figure 103), which 
was isolated for the first time as a natural product and its trimethyl ester derivative 
was prepared. Also isolated from the same fungus was spiculisporic acid (Figure 
103); the first instance of isolation from a Xylaria fungus. The dimethyl ester of 
spiculisporic acid was also prepared.
Figure 103 Secondary metabolite isolated from the fungus A311R
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The fungus 6RD12 produced; cycloepoxydon a known compound, which has been 
isolated for the first time from a Xylaria fungus, and 4,5,6-trihydroxy-3-propyl- 
3,4,6,7-tetrahydro-l//-isochromen-8(5//)-one, which is a novel compound (Figure 
104).
cycloepoxydon 4,5,6-trihydroxy-3-propyl-3,4,6,7-
tetrahydro-1//-isochromen-8(5//)-one
Figure 104 Secondary metabolites isolated from the fungus 6RD12.
The fungi A217R and A517R produced cytochalasin D, (S)-mellein and (3S,4S)-4- 
hydroxymellein as main secondary metabolites (Figure 105) suggesting that the two 
fungi are the same species.
cytochalasin D (S)-mellein 4-hydroxymellein
Figure 105 Secondary metabolites isolated from fungi A217R and A517R
The fungus X04 (Xylaria cf. juruensis) produced 2-hydroxy-5-ethoxy-3- 
methylcyclohexa-2,5-dien-l,4-dione as a novel compound, coriloxin as the main
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secondary metabolite in addition to (R)-mellein (Figure 106) and a mixture of two 
isomers of the 4-hydroxymellein.
coriloxin 2-hydroxy-5-ethoxy-3- (R)-mellein
methylcyclohexa-2,5-dien-l,4-dione
Figure 106 Secondary metabolites isolated from X04 and 6RD8 fungi
The fungus 6RD8 produced (S)-O-methylmellein as the main secondary metabolite 
(Figure 107).
Me
H
OMe O
(S)-O-methylmellein
Figure 107 Secondary metabolite isolated from 6RD8 fungus
4,5,6-trihydroxy-3-propyl-3,4,6,7-tetrahydro-l//-isochromen-8(5//)-one, Coriloxin, 
cytochalasin D, mellein and 4-hydroxymellein were tested as anti-plasmodial agent 
against Plasmodium falciparum strain K l. 4,5,6-trihydroxy-3-propyl-3,4,6,7- 
tetrahydro-1 //-isochromen-8(5//)-one gave IC50 = 3.74 pg/mL (mean of two 
experiments). Coriloxin gave IC50 = 2.22 pg/mL (mean of two experiments), whilst 
the other compounds showed no activity at the highest dose tested (50 pg/mL).
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